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An fNIRS study of the effects of medication on cognitive functioning and cerebral 
hemodynamics in adults with Attention-Deficit Hyperactivity Disorder 
Danielle D. Brinckman 




Background: Current research indicates clear distinctions between the general 
population and individuals diagnosed with Attention-Deficit/Hyperactivity Disorder 
(ADHD), specifically in cognitive processes and physiological brain activity. Stimulant 
medications have been shown to improve and, in some cases, normalize dysfunction in 
both these areas. The majority of extant brain imaging literature has included functional 
magnetic resonance imaging (fMRI) in tandem with neuropsychological tests to explore 
these relationships. However, functional near-infrared spectroscopy (fNIRS) is a 
promising neuroimaging technology that offers some unique features including 
portability, ecological validity, and the ability to detect brain activity via concentrations 
of oxygenated and deoxygenated blood. Very few studies have used fNIRS as a tool to 
investigate the impact of medication on adults with ADHD, both in their cognitive 
functioning and brain hemodynamics. However, there is evidence that this technology 
may—in addition to providing novel information about cognitive and physiological 
functioning—actually be better suited to evaluating the ADHD population.  
Objectives: The present study sought to: 1) compare differences in cognition (using 
neuropsychological tests) and neurophysiology (using fNIRS) between adults with 
ADHD (when unmedicated) and age-, gender-, and education-matched healthy control 
(HC) adults, and 2) compare differences in cognition and neurophysiology between 
medicated and unmedicated states in adults with ADHD. Ultimately, the goal was to 
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investigate the potential application of fNIRS as an assessment tool for both diagnostic 
(of the physiological underpinnings of the disorder) and monitoring (of the effectiveness 
of cognition-improving medications) purposes.  
Participants: Nine individuals aged 18-25 diagnosed with ADHD and nine age-,  
gender-, and education-matched healthy control participants (HCs). 
Method: All participants completed two testing sessions. HCs completed both sessions 
under normal conditions whereas ADHD participants completed one testing session while 
medicated and the other while unmedicated. Cognitive testing focused on working 
memory, a domain relevant to ADHD. Testing included 1) a two-subtest WAIS-IV; 2) a 
Sternberg delayed recognition task (a test of working memory); and 3) a visual n-back 
task (another working memory test). The latter two tasks were completed while 
participants were connected to a continuous wave fNIRS system to record cerebral 
hemodynamic activity during working memory performance. Demographic variables, 
confirmation of diagnosistic status, medications, and recent daily activities regarding 
caffeine, alcohol, tobacco, and other behaviors that could impact fNIRS data were 
recorded. 
Results: Cognitively, while healthy controls performed better on working memory tasks 
than ADHD participants, and ADHD participants generally performed better when 
medicated than unmedicated, neither comparison reached significance. Physiologically, 
there were no significant differences in PFC activation between the HC and ADHD 
groups, nor between medicated and unmedicated states within the ADHD group.  
Conclusions: The findings of this study mirror previous findings of the cognitive effects 
of medication in ADHD. Not surprisingly, individuals with ADHD performed working 
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memory tasks less accurately and more slowly than controls and the intake of stimulant 
medication led to an improvement in performance that reached levels similar to healthy 
individuals. By contrast, the medication-induced working memory improvements among 
adults with ADHD were not reflected in corresponding physiological changes measured 
by fNIRS. The lack of significant findings in this study may be due to low statistical 
power, though alternative explanations are also explored. Nonetheless, before fNIRS can 
contribute to clinical diagnosis and treatment of ADHD, more research is needed to 










 Current research indicates that there are clear distinctions between the general 
population and individuals diagnosed with Attention-Deficit/Hyperactivity Disorder 
(ADHD), with respect to cognitive processes and physiological brain activity. 
Additionally, stimulant medications have been shown to improve functioning in both of 
these areas for individuals diagnosed with ADHD. The majority of brain imaging 
literature has included functional magnetic resonance imaging (fMRI) in tandem with 
neuropsychological tests to examine these areas. However, functional near-infrared 
spectroscopy (fNIRS) is another neuroimaging technology that offers some unique 
features including portability, ecological validity, and the ability to detect brain activity 
via concentrations of oxygenated and deoxygenated blood. To date, very few studies have 
used fNIRS as a tool to investigate the combined cognitive and physiological differences 
between individuals with ADHD and their healthy counterparts, or the impact medication 
has on adults with ADHD both in their cognitive functioning and brain hemodynamics. 
Results from existing neuroimaging studies that have investigated these variables 
(together or separately) have been limited in various ways, including small sample sizes, 
limited use of neuropsychological tests (i.e., using only one measure to gain an 
understanding about a large functional domain), and susceptibility to the hyperactive 
movement common among individuals with ADHD. In contrast, fNIRS may be better 
suited for evaluating this population, as it provides a valid measure of frontal lobe 
activity (which is central to the cognitive dysfunction in ADHD), is robust during 
movement (another issue for those diagnosed with the disorder), and can provide novel 
information about cognitive and physiological functioning in ADHD, specifically 
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concerning blood flow. There were two aims to the present study: Aim 1 sought to 
examine the differences in cognitive performance and cerebral physiology between 
healthy control (HC) adults and adults with ADHD (when unmedicated). Aim 2 sought to 
examine the differences in cognitive performance and cerebral physiology between 
medicated and unmedicated states in adults with ADHD. 
1.1 Attention Deficit Hyperactivity Disorder 
While the majority of research in ADHD has focused on children, there is a 
growing body of literature examining adults. ADHD is a neurodevelopmental behavioral 
disorder characterized by age-inappropriate symptoms of inattention, hyperactivity, and 
impulsivity (American Psychiatric Association [APA], 1994, 2000). These symptoms 
must be observed early in life (before age 7), pervasive across situations, and chronic. 
With a prevalence rate of 3-9.5% (APA, 1994; Froehlich et al., 2007; Centers for Disease 
Control and Prevention [CDC], 2010), ADHD is the most frequently diagnosed 
psychological disorder in school-aged children. Sixty-five percent of cases persist into 
adulthood (Barkley, Fischer, Smallish, & Fletcher, 2002; Biederman et al., 2006), 
resulting in an estimated prevalence rate of 4% among the adult population that is 
affected with the disorder (Faraone & Biederman, 2005; Kessler et al., 2006). Various 
studies have found that children, adolescents, and adults diagnosed with the disorder 
exhibit similar clinical features including inattention and distractibility, as well as 
disruptions in both academic and occupational domains (Biederman, Mick, & Faraone, 
2000; Hechtman, 1992; Mannuzza, Klein, Bessler, Malloy, & LaPadula, 1993; Spencer, 
Biederman, & Mick, 2007; Taylor, Chadwick, Heptinstall, & Danckaerts, 1996); similar 
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findings in brain abnormalities have also been suggested, as described below (Seidman, 
Valera, & Bush, 2004). 
1.1.1 Neural Correlates of ADHD 
Structural and functional neuroimaging studies have consistently found a variety 
of structures and networks to be implicated in ADHD. A compilation of evidence 
suggests that when the clinical features carry into adulthood, so too do the structural and 
functional deviations (Cubillo, Halari, Smith, Taylor, & Rubia, 2012). Specific 
abnormalities are discussed below. 
1.1.1.1 Structural Neural Correlates 
Multiple studies have indicated that decreased volumes of specific brain structures 
and reduced cortical thickness occur in individuals with ADHD. Most notably, 
abnormalities have been found in: overall cortical gray matter, fronto-striatal structures 
(lateral prefrontal and dorsal cingulate cortices, caudate, and putamen), medial frontal 
regions (rostral anterior cingulate cortex and supplementary motor area), and the 
temporo-occipito-parietal junction (Bush et al., 2005; Cubillo & Rubia, 2010). 
Presumably, these structural differences translate into the cognitive differences observed 
among individuals with ADHD, as there are unique relationships between areas of the 
brain and cognitive functioning. In terms of the fronto-striatal structures, the dorsolateral 
and ventrolateral prefrontal cortices (DLPFC and VLPFC, respectively) are believed to 
play a role in an array of domains including vigilance, attention (selecting, dividing, and 
shifting), working memory, planning, and other executive functions (Bush et al., 2005; 
Duncan & Owen 2000; Posner & Peterson 1990). Additionally, the VLPFC has been 
linked to behavioral inhibition. The dorsal anterior cingulate cortex is thought to be 
4 
associated with motivation, complex cognitive processing, response selection and 
inhibition, target detection and error detection, and performance monitoring. Especially 
relevant to functioning in ADHD is the fact that there is evidence to suggest that this area 
also has a role in modulating reward-based decision making. 
Moreover, the medial frontal regions have been implicated in response selection 
and initiation behaviors. Thus, the deviations from normality in these structures as well as 
their connections with striatal, cerebellar, and parieto-temporal areas likely contribute to 
the observed deficits in the above behaviors in the adult ADHD population (Cubillo & 
Rubia, 2010). 
1.1.1.2 Functional Neural Correlates 
Consistent with structural evidence that grossly implicates dysfunction of the 
frontal lobes in ADHD, multiple neuroimaging (fMRI and PET) meta-analyses and 
reviews have reported corresponding functional abnormalities in the frontal lobe (Aron & 
Poldrack, 2005; Bush et al., 2005; Cubillo & Rubia, 2010; Dickstein, Bannon, 
Castellanos, & Milham, 2006; Paloyelis, Mehta, Kuntsi, & Asherson, 2007). Specifically, 
hypoactivity in the anterior cingulate, dorsolateral prefrontal, and inferior prefrontal 
cortices has been most commonly reported. In their review, Cubillo & Rubia (2010) 
concluded that reduced activation occurs during tasks targeting motor inhibition (e.g., 
Go/No-go), attention and interference inhibition (e.g., Color-Word Stroop, Simon or 
Eriksen Flanker tasks), and working memory (e.g., digit span, n-back).  
Similarly, fNIRS studies with adult and child/adolescent participants of cognitive 
function in ADHD have consistently reported a lower level of activation (i.e., reduced 
levels of oxygenated blood in the brain) during various cognitive tasks including the 
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Go/No-Go, Stroop, n-back, and verbal fluency tests (Ehlis, Bahne, Jacob, Herrmann, & 
Fallgatter, 2008; Inoue et al., 2012; Kobel et al., 2009; Negoro et al., 2010; Schecklmann 
et al., 2009). Only one child study using fNIRS found that ADHD participants exhibited 
an increase in oxygenated hemoglobin (HbO2) and cerebral blood volume (CBV) during 
a cognitive task (Weber, Lutschg, & Fahnenstich, 2005); however this task (trail making) 
focused on attentional abilities whereas others have focused more on working memory 
and executive functioning, and this could explain the discrepancy. In sum, current 
research suggests that both structural and functional abnormalities occur particularly in 
frontal cortical areas and are consistent with the cognitive dysfunction observed in 
individuals with ADHD, findings which the present study is designed to build on. 
1.1.2 Neuropsychological Profile of ADHD  
While a majority of ADHD research to date has been carried out with children 
and adolescents, the field has recognized the importance of gaining a better grasp of the 
disorder in adults in order to improve understanding of the disorder throughout the 
lifespan. This can be seen in the growth of literature specifically reporting on adult 
ADHD. Much of this research has found that many symptoms and difficulties found in 
children are also seen in adults, with neuropsychological dysfunction a consistent feature 
of adults with ADHD (Faraone et al., 2000; Woods, Lovejoy, & Ball, 2002). 
Various reviews and meta-analyses have reported that, similar to children, adults 
with ADHD experience deficits in multiple domains of function, the most prominent 
impairments consistently occurring in speed of complex information processing, attention 
and executive functions (e.g., tasks of verbal fluency, inhibition, and set shifting), and 
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working memory (Boonstra, Oosterlaan, Sergeat, & Buitelaar, 2005; Cubillo et al., 2012; 
Hervey, Epstein, & Curry, 2004; Woods et al., 2002). 
Other studies have investigated common complaints related to cognitive and 
neuropsychological functioning in adults with ADHD. Time-related issues appear to be 
prominent, particularly problems meeting deadlines, completing tasks, and planning 
(Riccio et al., 2005). A review of the literature by Davidson (2008) revealed that the most 
commonly reported complaints among adults with ADHD are problems with 
procrastination, frustration, poor motivation, insomnia, and time-management difficulties.  
1.1.3 Pharmacology: Effects of Medication on Individuals with ADHD 
1.1.3.1 Effects of Medication on Cognition 
Various types of medication exist for the treatment of symptoms associated with 
ADHD.  Stimulants such as Methylphenidate (MPH) have been shown to be the most 
effective—and therefore most prescribed—class of medications (Greenhill et al., 2002; 
Safer & Malever, 2000). Stimulants such as MPH function via a mechanism that impacts 
two specific neurotransmitters: dopamine (DA) and norepinephrine (NE; Volkow et al., 
2004). Specifically, MPH increases extracellular levels of DA and NE by blocking their 
respective transporters. Because DA and NE are responsible for reducing the firing rate 
of background neurons that can distract an individual from the task at hand, it is theorized 
that MPH functions by increasing DA and NE, which helps decrease background noise in 
the service of improving cognitive function.  
 In their review of the literature, Swanson, Baler, and Volkow (2011) reported that 
stimulant medications led to improvements in an array of cognitive functions ranging 
from those that incorporated executive functioning (e.g., inhibition, working memory, 
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strategy formation, planning, and set-shifting) to those that did not (e.g., complex 
reaction time, spatial recognition memory reaction time, and delayed matching-to-
sample). Other single studies with adults have reported similar findings regarding 
cognitive improvement: Biederman et al. (2008) found that MPH improves performance 
on sustained attention and verbal learning tasks; Agay, Yechiam, Carmel, and Levkovitz 
(2010) found better digit-span test scores among medicated individuals; and Topaloglu et 
al. (2008) found that medicated ADHD participants’ reaction times during executive 
control tasks were more similar (i.e., shorter)—though not identical—to healthy 
controls’.  
Taken together, these findings suggest that stimulant medications successfully 
enhance cognitive functioning in individuals with ADHD. The present study capitalized 
on this evidence and we anticipated that the same findings would be observed when 
comparing medicated and unmedicated conditions among adults with ADHD. 
Additionally, the present study targeted the links between the cognitive deficits 
associated with adult ADHD and specific PFC neuroanatomy.  Subsequently, we 
anticipated neurophysiological differences between the medicated and unmedicated 
ADHD groups, as well as between the healthy control and the unmedicated ADHD 
groups, discussed in more detail below.  
1.1.3.2 Effects of Medication on Brain Physiology 
A variety of findings have been described for imaging studies with both children 
and adults regarding the effects of stimulant medications on brain activity and 
hemodynamics. Both PET and fMRI studies utilizing working memory and executive 
functioning tasks have found contrasting results. While some have found decreases in 
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regional cerebral blood flow (rCBF) or regional cerebral blood volume (rCBV) in the 
prefrontal cortex (PFC) during tasks (Mehta et al., 2000; Schweitzer et al., 2004; Szobot 
et al., 2003; Weber, Lutschg, & Fahnenstich, 2007), others have found increases in PFC 
rCBF (Schweitzer et al., 2003) or PFC activation (Bush et al., 2008; Epstein, et al., 2007; 
Kim, J. Lee, Cho, & D. Lee, 2001; Rubia et al., 2009; Rubia, Halari, Christakou, & 
Taylor, 2009; Shafritz, Marchione, Gore, Shaywitz, & Shaywitz, 2004; Vaidya et al., 
1998; Wong & Stevens, 2012). 
Far less fNIRS research has been conducted, yet a conflict still exists. Topaloglu 
et al. (2008) observed patterns of decreased oxyhemoglobin (HbO2) levels in MPH 
medicated adults (compared to their unmedicated selves) during a measure of attention, 
response inhibition, and cognitive flexibility, which they attributed to vasoconstriction. 
By contrast, Monden et al. (2012) observed a significant increase in HbO2 during a 
Go/No Go task after intake of MPH by children.  
The discrepancies among this literature could be due to various reasons, including 
imaging techniques, sample sizes, sample characteristics (e.g., adult vs. child; ADHD 
subtype), task type and difficulty, and medication regimens. Also, many of the studies 
only utilized one cognitive task, another factor that could have limited their findings. The 
present study aimed to address these limitations and contribute to the literature focused 
on adults in this area as well as provide some clarification on existing findings.  
1.2 Functional Near-Infrared Spectroscopy  
Providing visual information regarding the structure and function of the brain, 
neuroimaging is on the cutting edge of neuroscience research with a broad range of 
techniques available for different purposes. First described by Chance et al. (1993, 1998), 
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one of these techniques is functional near-infrared spectroscopy (fNIRS). fNIRS is a 
developing, noninvasive neuroimaging technology that utilizes the near infrared region of 
the electromagnetic spectrum (approximately 700-1000 nm) to detect brain activity via 
concentrations of oxygenated and deoxygenated blood.  
Like fMRI, fNIRS detects neural responses by monitoring the hemodynamic 
response induced by cognitive tasks. Performance on cognitive tasks requires energy, 
which causes an increase in metabolic demand. Subsequently, this brings about a 
hemodynamic response, which can be seen as the increase in various components 
including: total cerebral blood flow (tCBF), regional cerebral blood flow (rCBF), 
regional cerebral blood volume (rCBV), and regional cerebral blood oxygenation (rCBO; 
Roy & Sherrington, 1890). Changes in these physiological variables are detected by the 
fNIRS system.  
 This imaging technology is distinct from fMRI in that it utilizes the ratio of the 
optical properties of oxygenated hemoglobin (oxy-Hb; HbO2) and deoxygenated 
hemoglobin (deoxy-Hb; HHb), rather than their paramagnetic properties (as fMRI does). 
More specifically, fNIRS is based on the property that light in the near-infrared range can 
pass through skin, bone, and other tissues relatively easily and takes advantage of the 
distinct absorption characteristics of HbO2 and HHb in the near-infrared spectrum to 
determine tissue oxygenation during cognitive activation (Izzetoglu et al., 2005; 
Villringer, 1997). Once the headpiece is in place, near-infrared light is emitted from one 
light source, penetrates the outer cortical layers, and is captured again by a detector. The 
wavelengths of light that were reflected and absorbed during the process are then 
conveyed to the data acquisition computer, which identifies concentration changes in 
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HbO2 and HHb. In sum, fNIRS can record changes in brain activation and activity 
(Jobsis, 1977). 
1.2.1 Instrumentation  
There are many commercially available fNIRS systems with different hardware 
setups that are being used in various settings (Strangman, Boas, & Sutton, 2002). 
Currently, there are three specific types of systems: time-resolved (TR), frequency-
domain (FD), and continuous wave (CW), each having its own unique set of advantages 
and disadvantages. Both the TR and FD systems use lasers as light sources and measure 
changes or shifts in the phase and amplitude of the light as it passes through cortical 
tissue. Ultimately, these systems provide a more precise quantification of fNIR signals. 
CW systems use either continuous or a slow-pulsed light as the light source and measure 
the attenuation of amplitude of the incident light as it travels through cortical tissue. Due 
to having less sophisticated detectors, CW systems provide slightly less information 
regarding timing of changes. However the benefit of CW systems is that the hardware is 
more compact and inexpensive, and therefore more useable for a larger variety of 
applications. The fact that they do not need to employ lasers (although they have this 
capability) also increases the safety of the CW system. Lastly, within the above systems, 
there are two additional options in terms of setup. While some use a cap that covers the 
entire scalp, others use a sensory pad that is placed on the forehead, focusing solely on 
frontal cortical activity.  
The Drexel system is a CW-fNIRS system that has been successfully used in a 
range of studies measuring brain activity during various cognitive tasks (Arenth, Ricker, 
& Schultheis, 2007; Ayaz et al., 2012; Irani, Platek, Bunce, Ruocco, & Chute, 2007; 
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Merzagora, Schultheis, Onaral, & Izzetoglu, 2011). It is comprised of three main 
components: a flexible headpiece, a control box, and a computer. The headpiece holds the 
fNIRS light sources/emitters and detectors/sensors; there are 4 light sources and 10 light 
detectors that, together, provide 16 channels for analysis. The sources and detectors are 
separated by 2.5 cm, which allows the near-infrared light to penetrate to a depth of 
approximately 1.25 cm. The control box and computer function together in data 
acquisition.  
1.3 Advantages of fNIRS Over Current Methods for Studying Brain Activity in ADHD  
fMRI has been used in an array of studies assessing prefrontal functioning in 
ADHD. However, various technicalities associated with the technology hinder its use and 
prevent it from being the ideal imaging method for use with this population. By contrast, 
fNIRS has a variety of advantages over fMRI. Such advantages include the following:  
• Scanner Apparatus/Environment: fMRI involves a large apparatus for scanning 
and requires that individuals lie as still as possible inside of a loud and confined 
environment. Conversely, fNIRS is a compact, less restrictive, and quieter system. 
Not only does this allow individuals to be tested in a more relaxed, ecologically 
valid environment but provides flexibility and the opportunity for bedside use in 
both clinical and research settings (Ehlis et al., 2008; Villringer, Plancka, Hock, 
Schleinkoferc, & Dirnagla, 1993). Additionally, its compact size makes it more 
portable and employable in a larger range of settings. 
• Scanning Time: fMRI requires a relatively long scanning time. This poses a 
problem when testing individuals diagnosed with ADHD, as symptoms such as 
distractibility, impulsivity, and hyperactivity can make it difficult for them to 
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endure the length of a long testing session (Schecklmann, et al., 2008). fNIRS 
surpasses this barrier by requiring much less time for measurement. 
• Motion Susceptibility: fMRI—and similar functional imaging techniques—are 
limited in that they are very sensitive to body movement. This can be 
exceptionally problematic when testing individuals diagnosed with ADHD, who 
are more prone to be distracted and/or hyperactive and unable to remain still 
during scanning (Ehlis et al., 2008). Even small movements can lead to motion 
artifacts in the obtained neurological scans, reducing accuracy of those scans 
(Monden et al., 2012). By contrast, fNIRS is more robust to movement and 
motion artifacts, which allows more flexibility for testing in naturalistic settings 
that involve movement, when necessary (Ehlis et al., 2008). This technology has 
even been employed with success in studies where body movement has been a 
factor (Herrmann, Ehlis, & Fallgatter, 2004; Herrmann, Plichta, Ehlis, & 
Fallgatter, 2005; Hock et al., 1997; Matsuo, Kato, Fukuda, & Kato, 2000; Matsuo 
et al., 2003; Shinba et al., 2004; Suto, Fukuda, Ito, Uehara, & Mikuni, 2004; as 
cited in Monden et al., 2012). 
• Expense: fNIRS is a more affordable system than other technologies. This, in 
turn, makes it a more accessible system to researchers. 
• Unique Capabilities: While fMRI only detects changes in HHb, fNIRS is able to 
detect changes in both HHb and HbO2 (and the ratio between them) as well as 
cytochrome aa3, an enzyme of the respiration chain (Fallgatter, Ehlis, Wagener, 
Michel, & Herrmann, 2004; Obrig & Villringer, 2003; Strangman et al., 2002). 
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This not only allows fNIRS to provide additional information but also provides a 
unique signal and view of the hemodynamics of the brain. 
Additionally, as previously discussed, both neuroanatomical anomalies and 
neurocognitive deficits in ADHD occur largely within the PFC and nearby structures. 
Therefore, fNIRS is an ideal assessment tool given the nature of the neuronanatomy 
associated with the disorder, as it is currently able to penetrate cortical areas to measure 
activity.  
1.4 Present Study 
In summary, while the current literature has touched on the individual aspects 
central to the current study, none have combined these aspects into a single study. 
Moreover, there are limiting factors involved in previous studies that were improved 
upon in the present design. Such factors include limited use of neuropsychological tests 
(i.e., using only one measure to gain an understanding about a large functional domain), 
and use of neuroimaging technologies (mainly fMRI and PET) susceptible to hyperactive 
movements that commonly occur in the ADHD population. In contrast, fNIRS may 
actually be better suited to evaluating this population, as it provides a good measure of 
frontal lobe activity (which is central to the cognitive dysfunction in ADHD), is robust to 
movement (another issue for those diagnosed with the disorder), and can gather novel 
information about cognitive and physiological functioning in ADHD (specifically 
concerning the blood flow). Thus, the present study was designed to address some of the 
above gaps that still remain in the literature. Aim 1 of the present study sought to 
examine the differences in cognition and cerebral physiology between healthy 
control (HC) adults and unmedicated adults with ADHD. If fNIRS can identify 
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differences in prefrontal neural activity commensurate with differences in cognitive 
functioning between healthy and clinical samples, this would lend support for the 
application of fNIRS in the clinical assessment of physiological underpinnings of 
neurocognitive disorders.  
Additionally, although the current literature includes a considerable amount of 
research assessing cognitive functioning in adults who are medicated for treatment of 
ADHD, only one thus far has used fNIRS to measure brain activity during cognitive tasks 
under both medicated and unmedicated states. Further, a clear understanding of the effect 
of stimulant medication on brain physiology in adults with ADHD is also missing from 
the present literature (and even literature for this in children and adolescents is limited). 
Although studies have examined the effect that medication has on cognitive tasks, very 
few have combined this with the physiology involved. Aim 2 of the present study 
sought to examine the differences in cognition and cerebral physiology between 
medicated and unmedicated states in adults with ADHD. The present study examined 
functioning at the cognitive and physiological levels, as well as any correlations that 
existed between these levels.  
Formal Statement Of Proposed Study Aims 
Aim 1. To examine the differences in cognition and cerebral physiology between 
healthy control (HC) adults and adults with ADHD (when unmedicated). 
Hypothesis 1: HC adults will perform significantly better on cognitive tasks than adults 
with ADHD (when unmedicated). 
Hypothesis 2: When completing cognitive tasks, unmedicated ADHD adults will show 
lower levels of activation (i.e., lower levels of blood oxygenation) than HCs.  
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Hypothesis 3: Hemodynamic activity, as detected by fNIRS, will be correlated with 
cognitive performance. 
Aim 2. To examine the differences in cognition and cerebral physiology between 
medicated and unmedicated states in adults with ADHD. 
Hypothesis 4: ADHD adults will perform significantly better on cognitive tasks when 
medicated (i.e., they have taken their prescribed dosage of stimulant medication) than 
when unmedicated. 
Hypothesis 5: When completing cognitive tasks, ADHD adults will show higher levels 
of activation (i.e., higher levels of blood oxygenation) when they are medicated than 
when unmedicated.         
Hypothesis 6: Hemodynamic activity, as detected by fNIRS, will be correlated with 
cognitive performance. 
2. METHOD 
2.1 Participants  
This study included 18 participants, ages 18-25 (M = 20.28, SD = 2.02), recruited 
from Drexel University and the Philadelphia area.  
2.1.1 ADHD Adults 
Participants with ADHD included nine adults, ages 18-25 years (M = 20.33, SD = 
2.29), who were diagnosed with ADHD by a psychologist or medical doctor and who had 
an established treatment regimen of at least one month with ADHD medication. ADHD 
diagnostic status was assessed with the Barkley Adult ADHD Rating Scale-IV (BAARS-
IV; Barkley, 2011). ADHD diagnosis was based on meeting DSM-IV-TR (APA, 2000) 
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criteria, as surveyed by the BAARS-IV, followed by confirmation of the diagnosis from 
the participant’s prescribing physician. 
2.1.2 Age-, Gender-, and Education-matched Healthy Adults  
Participants in this group included nine adults, each within 2 years of the 
chronological age of a participant with ADHD and also matched on gender and education 
level.  The age range of this group was very similar to that of the ADHD group (range = 
18-24 years, M = 20.22 years, SD = 1.86). 
2.2 Measures 
 All study participants completed all of the following measures.  
2.2.1 ADHD Screen 
 Participants were assessed with the following validated ADHD screen in order to 
determine ADHD diagnostic status: 
• Barkley Adult ADHD Rating Scale-IV (BAARS-IV): The BAARS-IV (Barkley, 
2011) is a screening tool for adults with ADHD (ages 18-89 years) that provides 
self-assessment of symptoms and their impact on domains of daily function across 
two time periods: current and childhood. It is based on DSM-IV-TR (APA, 2000) 
diagnostic criteria and takes approximately 5-7 minutes to complete. Further, it is 
normed by age group and retrospective report (i.e., presence of symptoms in 
childhood), thus providing a reliable measure of meeting a diagnosis of ADHD in 
adults. 
• Participants with a positive screen were further evaluated by a follow-up 
confirmation of diagnosis with their prescribing doctor.  
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2.2.2 Intelligence 
 Participants were assessed with the following IQ measure to gather information 
about their fundamental ability and what could be expected of their performance on the 
cognitive tasks. 
• Wechsler Adult Intelligence Scale—Fourth Edition (WAIS–IV): The two-subtest 
version of the WAIS-IV (Wechsler, 2011) consists of Vocabulary and Block 
Design subtests and takes approximately 25-30 minutes to administer. With high 
reliability, this short form correlates well with the Full Scale IQ and provides a 
valid estimate of IQ.    
2.2.3 Cognitive Tasks 
 This study aimed to examine within-subject and between-group differences in 
adults without and with ADHD (under medicated and unmedicated states), on measures 
of cognitive performance, namely on measures of working memory. Thus, we selected 
the Sternberg Delayed Recognition Task (Sternberg, 1966) and a visual n-back task, two 
tests commonly used to assess these functions (Sternberg, 1966). One benefit of using 
these tasks is that they are common to previous imaging studies with ADHD samples. 
Another benefit of using these tasks is that they are known to engage and activate the 
PFC (Manoach et al., 1997; Molteni, Butti, Bianchi, & Reni, 2008; Narayanan et al., 
2005; Owen, McMillan, Laird, & Bullmore, 2005), a cortical area in which fNIRS is fully 
capable of measuring activity. The following cognitive tests were administered to each 
participant while connected to the fNIRS apparatus. 
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2.2.3.1 N-Back Task 
 The n-back is a task that has been widely used to assess working memory (Owen 
et al., 2005). More specifically, the n-back involves three load conditions in which 
stimuli are single, upper-case consonants presented in pseudo-random sequence on a 
computer monitor. Participants were asked to view the computer screen and press a 
specified button with their dominant hand for any stimulus that is a repeat of the same 
letter presented “n” positions ago (with “n” equal to 0-, 1-, and 2-positions ago). Thus, 
for the 0-back condition, participants were asked to press a button as soon as the stimulus 
target letter (e.g., “X”) appeared on the screen. In the 1-back condition, participants were 
instructed to press a button as soon as they identified any stimulus matching the letter 
presented immediately before it (i.e., the target was one presentation back). For example, 
participants would press a button when they saw an “M” immediately following another 
“M.” In the 2-back condition, participants were instructed to press a button as soon as 
they identified any stimulus matching a letter shown two presentations back. For 
example, participants would press a button when they saw an “M” that appeared two 
presentations after a previous “M.” Participants were instructed not to press any buttons 
when a nontarget stimulus letter was presented.  
In this study, participants were provided with on-screen instructions (7.5 second 
duration) regarding the task condition (0-, 1-, or 2-back) to be performed at the start of 
each block. Each block was comprised of 20 stimuli total (6 targets and 14 nontargets). 
Stimulus duration was 0.5 seconds, interstimulus delay was 2.5 seconds, and each block 
was followed by a 10 second rest period. The experiment protocol included five 
presentations each comprised of a randomized order of one 0-back block, one 1-back 
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block, and one 2-back block.  Thus, each participant viewed a total of 15 blocks, 
ultimately comprised of three 0-back, three 1-back, and three 2-back blocks total (see 
Figure 1). Total test duration was approximately 20-25 minutes. 
 
 
Figure 1. N-back Protocol 
In the visual n-back task three conditions were used to incrementally vary the working 
memory load from zero items (0-back condition) to two items (2-back condition). Each of 
the three conditions was presented five times total, in a randomized order. 
 
 
2.2.3.2 Sternberg Delayed Recognition Task 
 The Sternberg Working Memory Task (Sternberg, 1966) is a brief (i.e., 
approximately 15-20 minutes) task that has been widely used to assess working memory 
because it incorporates processes critical to working memory: simultaneous storage and 
processing of information (Baddeley, 1986). In this task, participants were shown a 
stimulus set comprised of a series of consonants on a computer screen. The task required 
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participants to maintain the stimulus set in memory while differentiating target letters 
from foils based on the probe that is presented after a brief delay (Figure 1). The task is 
designed to capture performance across three memory loads of increasing difficulty (i.e., 
2-letter, 4-letter, and 6-letter stimulus sets). Reponses were made by having participants 
press one pre-specified button when the probe was part of the original stimulus set (i.e., 
when it was a target) and a different pre-specified button when the probe was not part of 
the original stimulus set (i.e., when it was a foil); the dominant hand was used for all 
manual responses.  
At the outset of this task, participants were provided with visual instructions (of 
unlimited duration) about the task to be performed. Participants viewed a total of 54 trials 
comprised of a randomized presentation of 18 2-letter stimulus sets, 18 4-letter stimulus 
sets, and 18 6-letter stimulus sets across and within participants. Each trial consisted of a 
2-second blank screen, followed by a 4-second stimulus set presentation, 0.5-second rest 




Figure 2. Sternberg Protocol 
In the Sternberg delayed recognition task, three conditions were used to incrementally 
vary the working memory load (i.e., a 2-letter, 4-letter, and 6-letter stimulus sets). Each 
of the three stimulus sets was repeated 18 times, in a randomized order. The figure lays 




Performance on both the Sternberg and N-back tasks is measured in terms of 
reaction time (to target stimuli) and accuracy (% correct for both target and non-target 
stimuli). These measures are significant to PFC function, as both reflect information 
processing during working memory tasks; presumably, the faster and more accurately one 
completes a task, the better the integrity of the PFC. Thus, for both tasks it is expected 
that higher accuracy and lower reaction times will reflect better working memory 
performance and, hence, better PFC function.  
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2.3 fNIRS Instrumentation and Data Acquisition 
2.3.1 Instrumentation 
This study used a continuous wave fNIRS system to monitor PFC activity of 
participants (as described in Ayaz et al., 2012). Chance et al. (1998, 1993) first described 
this system and it has since been further developed at Drexel University (Philadelphia, 
PA), manufactured and supplied by fNIR Devices LLC (Potomac, MD; 
www.fnirdevices.com). The system is comprised of three main components: a flexible 
headpiece (sensor pad), which holds light sources and detectors; a control box for 
hardware management; and a computer that runs the data acquisition (Figure 3).  
 
 
Figure 3. fNIRS System Components 
The components of the fNIRS system include: a flexible headpiece with light sources and 






The positioning of light source and detectors on the sensor pad create a total of 16 active 
optodes (channels) that are used to monitor neural activity specific to the dorsal and 
inferior frontal cortices of the brain (Ayaz et al., 2006; Ayaz et al., 2012; Izzetoglu et al., 
2005). Each source emitted light at two different wavelengths in the near-infrared 
spectrum (i.e., 730 and 850 nm) and measures of emerging light intensity were obtained 
for each optode; sampling rate was 2 Hz. Changes in light absorption, as measured by 
fNIRS at each of the two wavelengths, were converted to changes in concentration of 
oxyhemoglobin (HbO2) and deoxyhemoglobin (HHb). COBI Studio software (Drexel 
University) was used for data acquisition and visualization (Ayaz et al., 2011).  
2.3.2 Data Acquisition and Processing 
For each participant, raw fNIR data from each of the 16 optodes was filtered to 
eliminate physiologically irrelevant data (e.g., respiration and heart pulsation effects) and 
equipment noise, as previously described (Ayaz, Izzetoglu, Shewokis, & Onaral, 2010; 
Izzetoglu et al., 2005). Each participant's data was checked for any potential saturation 
(when light intensity at the detector was higher than the analog-to-digital converter limit), 
coupling problems (hair trapped between optodes) and motion artifact contamination by 
means of visual inspection and a coefficient of variation based assessment signal quality 
assessment (Ayaz, Izzetoglu, Shewokis, & Onaral, 2010). Using time synchronization 
markers, fNIR data segments for rest periods and task periods (5 repetitions per 
participant for n-back task, 18 trials for the Sternberg task) were extracted. Average 
oxygenation changes for each optode were calculated using the modified Beer-Lambert 
Law (Obrig & Villringer, 2003; Villringer & Chance, 1997) for task periods with respect 
to baseline rest periods preceding each task (Ayaz, 2010). For each repetition/trial of the 
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given working memory task, oxygenation change (HbO2 – HbR) data for each optode 
was averaged according to the task workload (n-back: 0-,1-, and 2-back; Sternberg: 2-,  
4-, and 6-letter) and was used as the dependent measure similar to previous reported 
studies (Ayaz, Shewokis, Bunce, Schultheis, & Onaral, 2009; Ayaz et al., 2012; Ayaz, 
Willems, et al., 2010; Izzetoglu et al., 2011; Izzetoglu, Bunce, Onaral, Pourrezaei, & 
Chance, 2004). Subsequently, to obtain the average oxygenation changes for the DLPFC, 
data from optodes 3-6 and 11-14 were averaged for each participant and used for 
comparison purposes. 
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2.4 Procedure  
A summary of the study design and flow can be seen in Figure 4. 
 
 
Figure 4. Study Design 
The study included two groups: adults with ADHD and healthy controls. Each group 
proceeded through the study in a similar fashion, albeit steps surrounding consent and 





Participants were recruited through flyers posted throughout Drexel University’s 
campus and the surrounding Philadelphia community. Participants were tested at Drexel 
University and told that they could change their mind about participating at any time. All 
participants were compensated for participation with either extra credit (for 
undergraduate students) or $10 (for individuals from the community). 
Because of some procedural nuances that differ between ADHD and HC 
participants, separate procedures are described below, as they relate to each group.  
2.4.2 Procedure for ADHD Participants 
ADHD participants completed two testing sessions, both occurring at Drexel 
University: the first while unmedicated and the second while medicated. This part of the 
procedure was not counterbalanced for a combination of methodological reasons. First, 
the BAARS-IV needed to be completed in the first testing session in order to 
appropriately classify ADHD and HC participants. Second, we wanted to get an accurate 
measure of intellectual ability without the hindrance of cognitive dysfunction and so the 
WAIS-IV needed to be completed during the medicated testing session. Third, to prevent 
fatigue during testing, we wanted both study sessions to be roughly equal in length and 
therefore the BAARS-IV (and other intake questionnaires) and WAIS-IV needed to be 
completed in separate sessions, requiring the unmedicated/BAARS-IV/intake session to 
always be completed first and the medicated/WAIS-IV session to be second. However, 
measures were taken to prevent practice effects when comparing medicated to 
unmedicated states within the ADHD group—and ensure that any differences in 
performance or cerebral physiology were due to medication effects only—including 
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randomizing the presentation of experimental stimuli for the cognitive tasks both within 
and across participants, as well as incorporating a 10-14 day gap between testing 
sessions. The following describes the procedures involved with this group in more detail. 
To determine eligibility, all potential participants underwent a phone screen 
interview prior to enrollment in the study. Using a prepared script, questions were asked 
to ensure that neurological, medical, psychiatric, and other exclusion criteria were not 
met. Eligible individuals were invited to join the study and informed consent was 
obtained from all potential participants. Consent process took place over the phone, as the 
ADHD participants were required to understand and agree to the procedures for cessation 
of medication prior to their arrival to the first testing session, which was completed while 
unmedicated. 
Participants were then scheduled for the first session of the study. They were 
instructed to not take their medication for at least 24 hours prior to the testing session to 
allow the effects of the stimulant to wear off, thus providing a good measure of the 
individual’s unmedicated performance. All participants were also asked to refrain from 
other substances known to have an effect on regional cerebral blood flow (e.g., caffeine 
intake, alcohol intake, and exercise) for at least 24 hours prior to their testing session to 
prevent the effects these factors can have on fNIRS data (Laurienti et al., 2002; Levin et 
al., 1998).  
Upon arrival to the first testing session, ADHD participants underwent the 
BAARS-IV (Barkley, 2011) ADHD screen to confirm ADHD diagnosis. Medical consent 
was also obtained in order to verify the diagnosis with the participant’s prescribing doctor 
following the testing session. Regarding medication regimen, information pertaining to 
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medication type, dosage, and frequency of intake was carefully recorded. After having 
completed the above, participants then proceeded to the testing. 
During testing, participants were familiarized with—and connected to—the 
fNIRS system for the completion of the cognitive tasks. A visual n-back task and the 
Sternberg delayed recognition task were then explained and administered individually. 
Each task included a practice session in order to ensure that the participant understood the 
given task and was proficient in it before completing the experimental session. 
Experimental stimuli for both tasks were randomized across trials. 
The second testing session, (occurring 10-14 days after the first and 
approximately the same time of day) was completed while ADHD participants were 
medicated. During this session, participants first completed the two-subtest WAIS-IV and 
were then re-familiarized with—and connected to—the fNIRS system for the completion 
of the cognitive tasks (n-back and Sternberg tasks).  
2.4.3 Procedure for Healthy Control Participants 
Healthy control (HC) participants followed a very similar procedural flow as the 
ADHD group. Eligibility was determined by the same phone screen interview prior to 
being enrolled in the study and eligible individuals were invited to participant in the 
study. All potential participants were asked to refrain from substances known to have an 
effect on brain activity (e.g., caffeine intake, alcohol intake, and exercise) for at least 24 
hours prior to their testing session. 
Informed consent was obtained from potential participants upon their arrival for 
the first testing session but prior to participating in the testing session. Those who met 
criteria for inclusion in the study and completed informed consent were assessed with the 
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BAARS-IV (Barkley, 2011) ADHD screen to ensure that they did not meet criteria for 
ADHD. HC participants then proceeded to the testing session, which proceeded in the 
same manner as described in the ADHD participant procedure (i.e., HC participants 
completed the cognitive tasks while being connected to the fNIRS system).  
Like the ADHD group, during the second session, participants first completed the 
two-subtest WAIS-IV. Then, participants were re-familiarized with—and connected to—
the fNIRS system for the completion of the cognitive tasks (n-back and Sternberg tasks).  
3. RESULTS 
Two sets of analyses were completed for each variable of interest: 1) unmedicated 
ADHD participants compared to matched HC participants (only session 1 data for each 
group were used in these analyses), and 2) unmedicated ADHD participants compared to 
themselves when medicated. Session 2 data for the HC group was only used for the 
purpose of checking for practice/fatigue effects across working memory tasks.   
3.1 Participant Demographics  
Demographic characteristics of the study participants are provided in Table 1. The 
two groups did not differ significantly with respect to age (t(16) = 0.11, p = 0.91) or 
education (t(16) = -0.74, p = 0.47), as tested by independent samples t-tests. Group 
differences were also nonsignificant in performance on the WAIS-IV Vocabulary subtest 
(t(16) = 0.31, p = 0.76), WAIS-IV Block Design subtest (t(16) = 0.12, p = 0.91) or 
WAIS-IV FSIQ estimation (t(16) = 0.22, p = 0.83), suggesting that any differences noted 
between the HC and unmedicated ADHD groups on cognitive tests could not be 
attributed to differences in educational level and/or general intellectual ability.  
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Table 1. Participant Demographics 
Study participants were comprised of nine ADHD participants and nine age-, gender-, 
and education-matched control participants. Participants were tested with a 2-subtest 
WAIS-IV to estimate FSIQ. The table reports the mean (M) and standard deviation (SD). 
 
 ADHD HC 
 M ± SD M ± SD 
Number of Participants 9 9 
Education 14.67 ± 1.87 14.11 ± 1.27 
Age 20.33 ± 2.29 20.22 ± 1.86 
WAIS-IV Vocabulary 13.44 ± 3.01 13.11 ± 1.27 
WAIS-IV Block Design 10.78 ± 3.53 10.56 ± 4.33 




3.2 Cognitive Performance  
Performance of the participants on the n-back and Sternberg tasks was evaluated 
in terms of accuracy and reaction time.  For the n-back task, accuracy was calculated as 
the correct click ratio (d’), which was determined in the following way:  
d’ = percent correct responses – percent incorrect responses 
!! = ! !"#!$!!"!!"#$%!&!""!!"##$%&'!!"#$%!& ∗ 100 − !"#!$!!"!!"!#$%&'#(!""!!"##$%&'!!"!#$%&'#( ∗ 100  
For the Sternberg task, accuracy was calculated as the percentage of probes correctly 
identified. For both tasks, reaction time was measured by how long (in milliseconds) it 
took for the participant to respond to a target stimulus or probe, depending on the task.  
Potential practice effects on the n-back and Sternberg tasks were evaluated with 
data collected across testing sessions in the HC group. Contrasts of working memory 
performance between the first and second testing sessions revealed significant main 
effects of load on the performance measures of both the n-back (accuracy: F(2, 16) = 
25.78, p < 0.001; target reaction time: F(2, 16) = .506, p < 0.05) and Sternberg (accuracy: 
F(2, 16) = 5.52, p < 0.05; reaction time: F(1.24, 9.89) = 29.85, p < 0.001, Greenhouse-
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Geisser correction applied) tasks, but no significant differences in cognitive parameters 
between sessions (n-back accuracy: F(1, 8) = 1.55, p = 0.249; n-back target reaction time: 
F(1, 8) = 4.49, p = 0.07; Sternberg accuracy: F(1, 8) = 0.54, p = 0.48; Sternberg reaction 
time: F(1, 8) = 0.03, p = 0.86). Thus, results suggest there were no effects of prior 
exposure on later performance of these working memory variables in the context of this 
study. 
3.2.1 N-back Performance  
Accuracy 
For effects between the HC and unmedicated ADHD groups, accuracy (d’) was 
analyzed utilizing a 2 x 3 ANOVA (group: HC, unmedicated ADHD; load: 0-back, 1-
back, 2-back) with repeated measures on load. The main effect of load (F(2, 32) = 43.07, 
p < 0.001) reached significance, but no effect of group (F(1, 16) = 1.26, p = 0.28) or of a 
load by group interaction was observed (F(2, 32) = 0.48, p = 0.63). The effect of load 
was such that participants were less accurate as task difficulty increased (participants 
were significantly less accurate on the 1-back compared to the 0-back condition, the 2-
back compared to the 1-back, and the 2-back compared to the 0-back).  
For effects comparing medicated to unmedicated states within the ADHD group, 
accuracy (d’) was analyzed utilizing a 2 x 3 ANOVA (medication: on, off; load: 0-back, 
1-back, 2-back) with repeated measures on both factors. Similar to between group 
analyses, the main effect of load (F(2, 16) = 23.27, p < 0.001) reached significance, but 
no effect of medication (F(1, 8) = 0.13, p = 0.29) or of a load by medication interaction 
was observed (F(2, 16) = 1.34, p = 0.34). The effect of load was such that, irrespective of 
medication condition, participants were significantly less accurate on the 1-back 
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compared to the 0-back condition and on the 2-back compared to the 0-back; there was 
no difference in performance between the 1- and 2-back conditions. Figure 5 presents the 
n-back accuracy data for both of these sets of comparisons. 
 
 
Figure 5. Accuracy on the N-back Task 
Correct response ratio (d’) for HC participants and for ADHD participants on and off 
medication, at 3 n-back loads: 0-back, 1-back, and 2-back. This figure represents 2 sets of 
analyses: 1) comparison of HC and unmedicated ADHD adults and 2) comparison of 
unmediated and medicated states within ADHD adults. In comparing HC and 
unmedicated ADHD groups, there was a significant main effect of load but not of group, 
and there was no load by group interaction. In comparing on and off medication within 
the ADHD group, there was also significant main effect of load but not of medication 
state, and there was no load by medication interaction.  
 
Reaction Time 
Target reaction time was analyzed between the HC and unmedicated ADHD 
groups using a 2 x 3 ANOVA (group: HC, unmedicated ADHD; load: 0-back, 1-back, 2-
back) with repeated measures on load. The same parameter was analyzed between 
medicated and unmedicated states within the ADHD group using a 2 x 3 ANOVA 
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(medication: on, off; load: 0-back, 1-back, 2-back) with repeated measures on both 
factors. Comparisons showed main effects of load in both the HC vs. unmedicated 
ADHD (F(1.07, 8.55) = 9.71, p < 0.05, Greenhouse-Geisser correction applied) and 
ADHD on vs. off medication (F(1.04, 16.60) = 6.75, p < 0.05, Greenhouse-Geisser 
correction applied) analyses. Participants were slower to respond on the 1-back compared 
to the 0-back condition and on the 2-back compared to the 0-back, regardless of group 
membership or medication condition within the ADHD group. There were no main 
effects of group (F(1, 16) = 0.08, p = 0.79) or medication (F(1, 8) = 0.08, p = 0.79), nor 
interactions in either set of comparisons (HC vs. unmedicated ADHD: F(1, 16) = 2.70, p 
= 0.12; unmedicated ADHD vs. medicated ADHD: F(2, 16) = 0.34, p = 0.71). Figure 6 




Figure 6. Target Reaction Time on the N-back Task 
Target reaction time (ms) for HC participants and for ADHD participants on and off 
medication, at 3 n-back loads: 0-back, 1-back, and 2-back. This figure represents 2 sets of 
analyses: 1) comparison of HC and unmedicated ADHD adults and 2) comparison of 
unmediated and medicated states within ADHD adults. In comparing HC and 
unmedicated ADHD groups, there was a significant main effect of load but not of group, 
and there was no load by group interaction. In comparing on and off medication within 
the ADHD group, there was also a significant main effect of load but not of medication 
condition, and there was no load by medication interaction. 
 
3.2.2 Sternberg Delayed Recognition Performance 
Accuracy 
HC and unmedicated ADHD comparisons of accuracy were completed using a 2 x 
3 ANOVA (group: HC, unmedicated ADHD; load: 2-letter, 4-letter, 6-letter) with 
repeated measures on load. Results revealed a main effect of load (F(2, 32) = 5.72, p < 
0.01) but not group (F(1, 16) = 0.56, p = 0.47). However, there was a significant load by 
group interaction (F(2, 32) = 3.69, p < 0.05). An analysis of simple main effects of this 
interaction was nonsignificant for differences in accuracy between on and off medication 
performance at each Sternberg level; this is likely due to lack of power associated with 
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the small sample size. Simple pairwise comparisons (independent samples t-tests) were 
completed to further investigate medication differences but were nonsignificant (2-letter: 
t(16) = -1.75, p = 0.10; 4-letter: t(16) = -1.64, p = 0.12; 6-letter: t(16) = 1.14, p = 0.27).  
Sternberg accuracy between unmedicated and medicated states within the ADHD 
group were compared using a 2 x 3 ANOVA (medication: on, off; load: 2-letter, 4-letter, 
6-letter) with repeated measures on both factors. No significant main effects of load (F(2, 
16) = 3.36, p = 0.06) or medication condition (F(1, 8) = 2.29, p = 0.17) were detected in 
the ADHD on and off medication analysis and there was no load by medication condition 





Figure 7. Accuracy on the Sternberg Delayed Recognition Task 
Accuracy (% correct) for HC participants and for ADHD participants on and off 
medication, at 3 Sternberg loads: 2-letter, 4-letter, and 6-letter. This figure represents 2 
sets of analyses: 1) comparison of HC and unmedicated ADHD adults and 2) comparison 
of unmediated and medicated states within ADHD adults. In comparing HC and 
unmedicated ADHD groups, there was a significant main effect of load but not of group, 
and there was a load by group interaction. In comparing on and off medication states 
within the ADHD group, there were no significant main effects of load or medication 
condition and there was no load by medication interaction. 
 
Reaction Time 
HC and unmedicated ADHD groups were compared via a 2 x 3 ANOVA (group: 
HC, unmedicated ADHD; load: 2-letter, 4-letter, 6-letter) with repeated measures on 
load. There was a significant main effect of load (F(2, 32) = 20.22, p < 0.001) but not of 
group (F(1, 16) = 1.06, p = 0.32) and no interaction was present (F(2, 32) = 0.66, p = 
0.52).  The effect of load was due to increased reaction times with increasing difficulty.  
The ADHD group (on vs. off medication comparison) was analyzed via a 2 x 3 
ANOVA (group: unmedicated, medicated; load: 2-letter, 4-letter, 6-letter) with repeated 
measures on load. This revealed a main effect of load (F(2, 16) = 19.16, p < 0.001) but 
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not medication condition (F(1, 8) = 0.36, p = 0.56). However, there was a load by 
medication interaction (F(2, 16) = 7.10, p < 0.05). Simple main effects analysis of the 
interaction yielded no significant difference in reaction time between medication status at 
each Sternberg load; power may have been insufficient. Supplemental paired t-tests were 
also nonsignificant (2-letter: t(8) = 1.27, p = 0.24; 4-letter: t(8) = 1.46, p = 0.18; 6-letter: 
t(8) = -0.60, p = 0.57). Figure 8 presents the Sternberg reaction time data based on 
cognitive performance.  
 
 
Figure 8. Reaction Time on the Sternberg Delayed Recognition Task 
Reaction time (ms) for HC participants and for ADHD participants on and off 
medication, at 3 Sternberg loads: 2-letter, 4-letter, and 6-letter. In comparing HC and 
unmedicated ADHD groups, there was a significant main effect of load but not of group, 
and there was no load by group interaction. This figure represents 2 sets of analyses: 1) 
comparison of HC and unmedicated ADHD adults and 2) comparison of unmediated and 
medicated states within ADHD adults. In comparing on and off medication status within 
the ADHD group, there was also a significant main effect of load but not of medication 




3.2.2 Summary of Cognitive Findings  






























































































































































































































































































































































































































































































































































































































































































3.3 Physiological Data  
Baseline-corrected values of oxygenation changes (HbO2 – HbR; measured in 
micromolars) during the cognitive tasks were compared between the unmedicated ADHD 
and HC group using repeated measures 2 x 3 ANOVAs. It was not expected that there 
would be differences in lateralization of oxygenation changes and separate preliminary 
analyses of this parameter in left and right hemispheres confirmed this. Thus, 
oxygenation changes in left (optodes 3-6) and right (optodes 11-14) DLPFC regions were 
combined in the analysis of fNIRS data recorded during performance of each cognitive 
task.  
3.3.1 N-back fNIRS Data  
A comparison between n-back task-related oxygenation changes in the HC and 
unmedicated ADHD groups showed no significant main effect of load (F(1.27, 20.35) = 
0.81, p = 0.41, Greenhouse-Geisser correction applied) or of group (F(1, 16) = 0.58, p = 
0.46), nor was there a significant load by group interaction (F(2, 32) = 1.36, p = 0.27).  
Comparison between n-back task-related oxygenation changes in the medicated 
and unmedicated states within the ADHD group revealed significant main effects of load 
(F(2, 14) = 5.87, p < 0.05) but not medication condition (F(1, 7) = 0.41, p = 0.54), and 
there was no load by medication condition interaction (F(1.04, 7.30) = 3.15, p = 0.12, 
Greenhouse-Geisser correction applied). The effect of load was such that, irrespective of 
medication condition, participants’ blood oxygenation levels were significantly lower 
during the 1-back compared to the 0-back condition and on the 2-back compared to the 0-
back; there was no difference in performance between the 1- and 2-back conditions. 
41 
Figure 9 depicts the hemodynamic changes for each group during cognitive performance 
on each n-back condition. 
 
 
Figure 9. Hemodynamic Response During the N-Back Task  
Oxygenation changes elicited in the DLPFC by the 0-back, 1-back, and 2-back load 
conditions of the n-back task. This figure represents 2 sets of analyses: 1) comparison of 
HC and unmedicated ADHD adults and 2) comparison of unmediated and medicated 
states within ADHD adults. In comparing HC and unmedicated ADHD groups, there 
were no significant main effects of load or group, and there was no load by group 
interaction. In comparing medication status within the ADHD group, there was a 
significant main effect of load but not of medication condition, and there was no load by 
medication condition interaction. Note: Medicated ADHD averages do not include 1 




3.3.2 Sternberg Delayed Recognition fNIRS Data 
 Comparison between Sternberg task-related oxygenation changes in the 
medicated and unmedicated states within the ADHD group revealed no significant main 
effects of load (F(2, 12) = 0.67, p = 0.53) or medication condition (F(1, 6) = 0.95, p = 
0.37), and no load by medication condition interaction (F(2, 12) = 3.94, p = 0.05). 
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As with the n-back, comparison between Sternberg task-related oxygenation 
changes in the HC and unmedicated ADHD groups showed no significant main effects of 
load (F(1, 15) = 0.38, p = 0.69) or group (F(1, 16) = 0.62, p = 0.44), nor a significant load 
by group interaction (F(2, 30) = 0.92, p = 0.41). Figure 10 depicts the hemodynamic 
changes for each group during cognitive performance across Sternberg loads. 
 
 
Figure 10. Hemodynamic Response During the Sternberg Delayed Recognition Task  
Oxygenation changes in the DLPFC elicited by the retrieval trials of the 2-letter, 4-letter, 
and 6-letter load conditions of the Sternberg delayed recognition task. This figure 
represents 2 sets of analyses: 1) comparison of HC and unmedicated ADHD adults and 2) 
comparison of unmediated and medicated states within ADHD adults. In comparing HC 
and unmedicated ADHD groups, there were no significant main effects of load or group 
and there was no load by group interaction. In comparing on vs. off medication in the 
ADHD group, there were no significant main effects of load or medication condition and 
there was no load by group interaction. Note: Medicated ADHD averages do not include 
values for 2 participants and unmedicated ADHD averages do not include 1 participant’s 





3.4 Correlational Results  
 
The relationship between changes in cognitive performance (accuracy and 
response time) and the theoretically expected changes in hemodynamic response 
(oxygenation) on both the n-back and Sternberg tasks was directly investigated by means 
of parametric correlations (Pearson’s r) and performed separately for the HC, ADHD-
unmedicated, and ADHD-medicated groups. No significant relationships were found (see 
Tables 3A-C). Given the known limitations with fNIRS and the small sample size, it is 
not surprising that there are non-findings in the correlational data at this point.  
 
Table 3. Correlations Between Cognitive and Hemodynamic Variables 
Pearson's r and p values reported for each correlational analysis for HC (A), unmedicated 
ADHD (B), and medicated ADHD (C) groups. Correlations were assessed between the 
hemodynamic response (change in oxygenation) and performance variables (accuracy 
and reaction time) during cognitive tasks. All results were nonsignificant. 
 
(A) HC Group 
 Change in Oxygenation (μM) 
Test Variable Load r p 
N-back Accuracy 0 0.32 0.40 
1 -0.05 0.89 
2 0.09 0.82 
Target Reaction Time 0 -0.07 0.86 
1 0.27 0.49 
2 0.12 0.76 
Sternberg Accuracy 2 0.09 0.83 
4 0.19 0.63 
6 0.02 0.97 
 Reaction Time 2 -0.20 0.60 
4 0.08 0.84 
6 -0.62 0.08 
Note: Degrees of freedom = 7 
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(B) Unmedicated ADHD Group 
 Change in Oxygenation (μM) 
Test Variable Load r p 
N-back Accuracy 0 -0.04 0.93 
1 0.51 0.16 
2 -0.39 -.30 
Target Reaction Time 0 -0.28 0.46 
1 -0.28 0.46 
2 0.54 0.13 
Sternberg Accuracy 2 0.33 0.42 
4 0.17 0.68 
6 -0.07 0.86 
 Reaction Time 2 -0.69 0.06 
4 -0.05 0.90 
6 -0.33 0.42 
Note: N-back Degrees of freedom = 7; Sternberg Degrees of freedom = 6 
  
(C) Medicated ADHD Group 
 Change in Oxygenation (μM) 
Test Variable Load r p 
N-back Accuracy 0 -0.56 0.15 
1 -0.05 0.91 
2 -0.02 0.97 
Target Reaction Time 0 0.05 0.91 
1 -0.06 0.88 
2 -0.13 0.76 
Sternberg Accuracy 2 0.32 0.48 
4 0.39 0.38 
6 -0.38 0.40 
 Reaction Time 2 -0.51 0.25 
4 0.63 0.13 
6 0.04 0.93 





4.1 Findings and Implications  
The aims of this study were to examine within-subject and between-group 
differences in cognitive performance and cerebral physiology (measured with fNIRS) 
among adults with ADHD compared to healthy controls and compared to themselves 
when on versus off medication during working memory tasks. Although some previous 
research has separately examined cognitive and physiological differences between 
healthy and ADHD groups, and other research has examined the effect that medication 
has on cognitive task performance in ADHD, very few have combined the cognitive 
aspects with the physiology involved, particularly with the use of fNIRS. Additionally, 
there still remain uncertainties about the impact of stimulant medications on 
physiological changes in the ADHD brain, which we set out to investigate in this study. 
While few statistically significant differences were noted within and between 
these groups, several important trends in the data are worth noting.  For instance, with 
respect to cognitive performance, results unsurprisingly revealed that unmedicated 
ADHD adults performed most poorly, with the medicated ADHD adults performing 
better but yet not as well as healthy control participants. Further, this study showed that 
the same adults with ADHD demonstrated some degree of improvement on aspects of 
working memory when they completed these same tasks while medicated. The 
improvements noted for the medicated adults with ADHD resembled an overall level of 
working memory ability comparable to healthy control participants such that medicated 
ADHD adults demonstrated reaction times and accuracy rates on par with those 
demonstrated by healthy controls. Together, these findings suggest that stimulant 
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medications improve working memory-related cognitive functions and are consistent 
with improvements demonstrated in other studies (e.g., Agay et al., 2010; Biederman et 
al., 2008; Topaloglu et al., 2008; Swanson et al., 2011). 
With respect to physiological states in the PFC during working memory tasks, 
trends revealed that hemodynamic changes in the PFC within and across tasks were quite 
variable, dependent upon the group. In general, unmedicated ADHD adults demonstrated 
the greatest degree of variation in oxygenation changes in many task loads (i.e., larger 
range of values), compared to both themselves when medicated and the control group. 
This supported our predictions regarding the cognitive performance expectations for each 
group; that is, without medication, the ADHD brain functions less efficiently than the 
healthy brain, showing improvement when medicated. Outside of this trend, 
physiological changes did not correspond to changes in cognitive performance across 
groups, as originally expected; however, there was still an observable positive effect of 
medication on cognitive functioning, as seen in the cognitive data. Thus, this may be 
indicative of other possible mechanisms by which stimulant medications act that have yet 
to be addressed in the ADHD literature. 
4.1.1 Cognitive Performance 
 The cognitive tasks included in this study were designed to measure specific 
aspects of working memory and ultimately provided insight into a performance profile of 
strengths and weaknesses demonstrated by unmedicated adults with ADHD as compared 
to themselves when medicated as well as to healthy controls. Generally speaking, there 
was a great deal of variability and inconsistency within and across parameters of working 
memory, resulting in a lack of significant findings for group comparisons. However, this 
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study was not without significant results. Though not central to the aims of this study, 
task load consistently impacted both accuracy and reaction time performance in all 
groups, in agreement with the literature (e.g., Ayaz et al., 2012; Cairo, Liddle, 
Woodward, & Ngan, 2004; Miller, Price, Okun, Montijo, & Bowers, 2009; Sternberg, 
1969). Thus, the cognitive tasks sufficiently challenged participants as they were 
designed to do, and as expected, results showed that regardless of clinical diagnosis or 
medication status, increased task demands hinder working memory performance.  
Of note, there were a few paradoxical conditions that resulted in surprising 
findings for within- and between-group comparisons. First, accuracy on the 1-back load 
of the n-back task showed that ADHD performance dropped slightly when medicated. 
Second, reaction time results across the entire n-back task were quite unexpected: all 
groups showed a general decrease in reaction time with increasing task load and ADHD 
participants exhibited longer reaction times when medicated compared to when they were 
unmedicated. This may, in part, be explained by anticipatory response mechanisms, 
particularly for the ADHD group, as has been demonstrated in previous work (Perchet, 
Revol, Fourneret, Mauguière, & Garcia-Larrea, 2001). Lastly, both accuracy and reaction 
time in the 6-letter load of the Sternberg revealed unexpected results regarding group 
performance: ADHD participants performed better than controls and ADHD participants 
performed better when unmedicated than medicated. It should be noted that the reason for 
these unexpected results could not be identified by review/analysis of data acquisition 
procedures.  
Despite the nonsignificant, complicated, and somewhat paradoxical cognitive 
findings mentioned above, meaningful patterns in working memory functioning still 
48 
emerged. Working memory performance was measured via accuracy and reaction time, 
both reflecting cognitive ability and processing speed in this functional domain. 
Specifically, accurate information processing takes time and effort and therefore, the 
faster and more accurately one is able to complete a task, the greater the cognitive 
strength of one’s PFC (Luce, 1986; Sternberg, 1969; Townsend & Ashby, 1983). General 
trends across these parameters suggest that adults diagnosed with ADHD struggle with 
storage and retrieval aspects of working memory, yet respond favorably to stimulant 
medications that are designed to promote function more similar to healthy peers. 
Moreover, when unmedicated, adults with ADHD tend to demonstrate slower (and hence 
poorer) processing speed during working memory tasks compared to their healthy 
counterparts, similar to other adult ADHD studies (Biederman et al., 2008; Topaloglu, et 
al., 2008).  
The deficits described above are not unique to the adult ADHD population. 
Similar neuropsychological deficits in working memory and other cognitive domains 
have been identified across the lifespan (as reviewed in Swanson, et al., 2011). Although 
it has a lifetime trajectory, ADHD is typically conceptualized as a neurodevelopmental 
disorder beginning in childhood and examinations of its etiology have indicated that 
development of the cortical surface is delayed in the PFC in children with ADHD (Shaw 
et al., 2007; Shaw et al., 2012). This has led to a model of the disorder characterized by 
an early delay in brain development (particularly in frontal gray matter), rather than an 
overall or more sustained alteration in frontal lobe development, as the leading factor 
producing ADHD symptoms. Studies expanding these findings into adulthood do not yet 
exist, but it is possible that these early delays produce long-lasting cortical abnormalities 
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that are then seen in adulthood as cognitive deficits, which would be consistent with the 
pattern of cognitive results observed in this study. 
It has already been well established that, even in the healthy brain, the frontal 
lobes demonstrate a protracted pattern of development compared to other neural regions, 
and continue to develop into the third decade of life (e.g., Durston et al., 2001; Romine & 
Reynolds, 2005; Sowell, Thompson, Tessner, & Toga, 2001). These neuroanatomical, 
neurophysiological, and neurochemical changes correlate with the emergence of the 
capacity to acquire the skills necessary for higher cognition (Grattan & Eslinger, 1991). 
Combining this with the model of delayed frontal gray matter development in ADHD, it 
is possible that the ADHD brain is at an even greater disadvantage in its development 
across the lifespan and perhaps the frontal lobes remain more anatomically variable and 
underdeveloped into adulthood compared to healthy individuals, further hindering the 
working memory skills among those with the disorder.    
Fortunately, intake of stimulant medication has repeatedly been shown to improve 
working memory performance in the ADHD population, and this was demonstrated in the 
current study as well. Specifically, performance in both accuracy and reaction time 
parameters in the medicated ADHD group not only improved from their unmedicated 
state, but also resembled the performance level of healthy controls, aligning with 
previous work in the field (Kobel et al., 2009). Thus, the positive impact of medication is 
clear from a cognitive perspective; however, the specific mechanism(s) by which it acts 
and the neurophysiological effects it has remains unclear.  
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4.1.2 PFC Activation 
From a blood flow perspective, patterns of cerebral activation were inconsistent 
during both working memory tasks. Oxygenation changes in the PFC across tasks were 
quite variable, dependent upon the group and load, with no detectable trends of statistical 
significance; this was especially true of the ADHD group. Importantly, the HC group 
displayed some notable trends. A positive relationship between increasing workload and 
oxygenation in the DLPFC was observed during the n-back task (in agreement with both 
fNIRS and fMRI studies of healthy individuals; e.g., Braver et al., 1997; Ayaz et al., 
2012; Izzetoglu et al., 2005) and there was a negative relationship observed between 
increasing workload and oxygenation in the DLPFC during the Sternberg task. Thus, 
inconsistencies in the ADHD findings may speak to the inefficient functionality of the 
ADHD brain during working memory tasks (as described above). Furthermore, the 
unmedicated ADHD group generally demonstrated greater variability across tasks 
compared to the other groups, and variation within each of the groups themselves at each 
load level was notable. For example, the average change in oxygenation during the 4-
letter Sternberg for the unmedicated ADHD group ranged from -0.0779 to 0.1571 μM 
while the HC group and medicated ADHD group ranged from -.0293 to 0.0388 μM and   
-0.0353 to 0.0576 μM, respectively. Given the inconsistent findings in the literature 
concerning predictable changes in brain activation and the hemodynamic response (as 
described in sections 1.1.1.2 and 1.1.3.2), the variability we found is not surprising. Some 
studies have reported reduced levels of oxygenated blood during various cognitive tasks 
including those in the adult ADHD brain compared to the healthy brain (e.g., Ehlis et al., 
2008; Schecklmann et al., 2009). However, these studies employed a different fNIRS 
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system (ETG-4000, full head setup) and differences were identified in regions our system 
was incapable of measuring. Beyond this, the literature remains impoverished and those 
studies that do exist continue to find contradictory results. Additionally, conflicting 
findings of oxygenation changes under the influence of medication have also been 
reported (see Monden et al., 2012 and Topaloglu et al., 2008). To further complicate the 
literature, null group findings similar to those in this study have been found in prior work 
(Kobel et al., 2009; Schecklmann et al., 2010). For instance, Kobel et al. (2009) found 
that intake of Methylphenidate (MPH) led to a clear improvement on a behavioral level 
but this effect was not reflected in corresponding changes in functional brain 
organization.  
Although there is no one explanation for these findings, additional suggestions 
can be made for the interpretation of the pattern of results. One possibility rests on the 
currently accepted way of conceptualizing of the brain as a collection of interconnected 
networks, rather than on a one-to-one correspondence between brain structure and 
cognition. Although there is compelling evidence suggesting that frontostriatal 
dysfunction may be central to the pathophysiology of ADHD, neuroimaging findings 
point to distributed neural substrates, and there is now substantial evidence of structural 
and functional alterations in regions outside the frontostriatal circuitry in ADHD 
(Cherkasova & Hechtman, 2009). Imaging research has not only identified differences in 
PFC activation during cognitive tasks, but also in more posterior cortical regions 
including the parietal cortex, occipital lobe, and cerebellum (e.g., Hale, Bookheimer, 
McGough, Phillips, & McCracken, 2007; Kobel et al., 2008; Schweitzer at al., 2000; Silk 
et al., 2005; Valera, Faraone, Biederman, Poldrack, & Seidman, 2005; Vance et al., 2007; 
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Wolf et al., 2008). It is possible that the biggest (and therefore more easily detectable) 
physiological differences occur within posterior regions that were not captured in this 
study. Having only investigated one part of the network implicated in ADHD, we may 
have overlooked a larger process at work. This is not to say that there are no 
physiological differences that occur in the PFC, simply that any differences were not 
large enough to be detected within the current sample. Although we can only speculate at 
this point, the current data, viewed in the context of the broader literature, suggests this as 
one strong possibility. 
Additionally, the theory of cognitive reserve (Barnett, Salmond, Jones, & 
Sahakian, 2006) may help further explain our unexpected fNIRS findings. Sumowski and 
colleagues (2010) cited various studies that have consistently indicated intellectual 
enrichment (estimated with education or vocabulary knowledge) as a protective factor 
against cognitive impairment in other clinical populations including Alzheimer’s disease 
(Stern, Alexander, Prohovnik, & Mayeux, 1992; Alexander et al., 1997; Bennett et al., 
2003; Stern, 2006; Roe et al., 2008), stroke (Elkins et al., 2006), and multiple sclerosis 
(MS; Sumowski, Chiaravalloti, & DeLuca, 2009; Sumowski, Chiaravalloti, Wylie, & 
DeLuca). Intellectual enrichment ultimately enhances expression of the cognitive reserve 
network, which in turn reduces the negative impact of neuropathology on cognition (i.e., 
individuals with greater expression of the cognitive reserve network can withstand more 
severe brain disease before exhibiting cognition similar to patients with lesser network 
expression). Furthermore, in their study, Sumowski, Wylie, DeLuca, and Chiaravalloti 
(2010) conducted a similar working memory protocol to that of the present study and 
found that, while reaction time was unrelated to intellectual enrichment in the MS 
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population, intellectual enrichment was negatively associated with prefrontal recruitment, 
indicating that patients with lesser enrichment required more cerebral resources to 
perform the same cognitive task as patients with greater enrichment. In the present study, 
participants ranged from having 13-18 years of education. Due to the enhanced level of 
intellectual enrichment associated with an education at this level, it may be possible that 
the ADHD individuals possessed as much cognitive reserve as their healthy counterparts 
and therefore did not exhibit drastically different patterns of hemodynamic change (i.e., 
recruiting additional oxygen) during the cognitively demanding tasks.  
However, ADHD has largely been conceptualized as a neurodevelopmental 
disorder, and this may prevent an affected individual from necessarily having the ability 
to develop strong neuronal/synaptic density—and therefore a cognitive reserve—
throughout development. Thus, cognitive reserve may not be acting alone. An 
accumulating body of literature has indicated that early brain development is highly 
responsive to environmental influences (Halperin & Healy, 2011), and that there exists a 
relationship between exposure to environmental factors during neurodevelopment and 
occurrence of ADHD-like symptomatology (Pamplona, Pandolfo, Savoldi, Prediger, & 
Takahashi, 2009). Additionally, making modifications to the familial environment (e.g., 
partaking in cognitive training programs and social play groups for skill strengthening) 
has been suggested as a possible preventive strategy to ADHD. Such resources have been 
widely available for the present generation of individuals who are now young adults with 
the disorder (first reported by Cameron & Robinson in 1980), and—though not 
recorded—the participants in the current study may have been involved in similar 
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intervention programs as children and adolescents, aiding in the development of their 
cognitive reserve.   
Although some have argued that fNIRS has better temporal resolution than fMRI 
(Strangman, Culver, Thompson, & Boas, 2002), there are still limitations with its ability 
to directly capture cognitive responses (such as reaction times) in milliseconds; for such 
fast responses, EEG must be considered. For instance, fNIRS allows for the acquisition of 
an indirect hemodynamic response associated with the neural response underlying a 
cognitive task, rather than the immediate neural response itself. The signal measured by 
fNIRS, the hemodynamic response function (HRF), is a metabolic—and thus indirect and 
slow—correlate of neural activity. Peak response latencies are in the order of several 
seconds following stimulus onset, with a plateau of several seconds (depending on 
stimulus duration), and a slow return to baseline over 5-10 seconds or longer (Gervain et 
al., 2011). Within the context of the current literature surrounding hemodynamic latency 
in fNIRS, our study provides an additional factor that should be taken into consideration 
when using fNIRS to investigate hemodynamic changes during cognitive tasks: the task 
designs themselves. In both the n-back and Sternberg protocols, stimuli are presented so 
closely to one another that each evoked response is overlapped with the prior and 
following ones. Thus, in the present study, overlapping responses may have further 
complicated the intrinsic time delay of fNIRS measurement. That is, the neural activation 
we intended to measure may have occurred between the time neural processing was 
initiated with stimulus onset and the time its metabolic correlate was recorded by the 
fNIRS system. 
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A second weakness of using HRF is highlighted by/in the work of Huppert and 
colleagues (2006) who have posited that there exists a large degree of inter-subject 
variance in response time-to-peak, which was observed in the present study. Diurnal 
effects on brain activity have also been noted. Brinckman et al. (2012) observed variation 
both within and across healthy participants completing typical daily activities (e.g., 
reading) across the span of a day (i.e., 8 hours). They concluded that individuals 
experience different peaks and valleys of blood flow that change according to the time of 
day, and the timing of these peaks and valleys can vary substantially between individuals. 
Although participants in the current study completed both testing sessions at 
approximately the same time of day, the inconsistent hemodynamic results may be a 
reflection of diurnal variation across the sample, produced by different participants being 
tested at different times from one another. Thus, our data demonstrate support for the 
argument of physiologically based inter-subject differences as well as diurnal differences 
in the hemodynamic response, which could ultimately impact the interpretation of group 
comparisons. 
Ultimately, unanswered questions remain in the literature concerning the 
dynamics of the HRF in fNIRS. Currently, no such study exists that directly relates 
cognitive and hemodynamic responses in a mathematical fashion. Many studies 
acknowledge this shortcoming (e.g., Gervain et al., 2011; Huppert, Hoge, Diamond, 
Franceschini, & Boas, 2006) but have yet to develop a strategy to resolve the issue. 
Progress is being made to determine more precisely when the HRF peaks, but individual 
differences and differences across brain systems remain. Efforts have been made toward 
investigating and proposing methods for better standardizing the analysis of 
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hemodynamic changes using fNIRS (e.g., Schroeter et al., 2004), but the literature still 
lacks a definitive solution. 
4.2 Limitations 
A few limitations should be noted for a full understanding of the current findings. 
Similar to previous imaging studies with this population, the primary limitation of this 
study is the small sample size. Recruitment of ADHD adults was more difficult than 
anticipated and complicated by the fact that potential ADHD participants were excluded 
if they had been prescribed to take their medication only on an “as needed” basis. The 
rationale for the use of this stringent exclusion criterion was to 1) increase the probability 
of a reliable ADHD diagnosis, and 2) ensure that ADHD individuals included in the 
study had a steady regimen of stimulant medication (and therefore were accustomed to 
the daily benefits of it) that would lead to detectable cognitive and physiological changes 
during the washout period. Ultimately, however, this criterion may have limited the 
statistical power of results (by reducing sample size) and any null results should be 
interpreted with caution. Despite this important limitation, there is still evidence that 
supports meaningful and expected data trends in previous literature, as discussed above.  
The validity of ADHD diagnostic status is another possible limitation to the 
findings in this study. Because our diagnostic procedures for identifying the ADHD 
sample versus the healthy control sample relied primarily on self-report, participants who 
screened positive for ADHD may not have had a true diagnosis of the disorder. Follow-
up was completed with each ADHD participant’s prescribing doctor in order to obtain 
collateral diagnostic information; however, the gold standard procedure for arriving at a 
clinical diagnosis of ADHD in a physician’s office also relies only on patient self-report.  
57 
Additionally, participants with different ADHD subtypes and comorbidities were 
included in the study, increasing the heterogeneity of the ADHD group. Comorbidity of 
diagnoses such as anxiety, depression, and specific learning disability are very common 
with ADHD (Jensen, Martin, & Cantwell, 1997) and recruiting a patient sample 
diagnosed with ADHD alone would be difficult as this rarely occurs. Further, such a 
diagnostically “pure” group would not have been representative of the clinical disorder in 
the general population. Concerning subtypes, prior research has shown that the impact of 
stimulant medication does not differ based on diagnostic subtypes (Barkley, DuPaul & 
McMurraym, 1991) and therefore the heterogeneity resulting from the inclusion of 
different subtypes should not have impacted results. On the other hand, it is possible that 
other factors within the ADHD sample influenced heterogeneity and, subsequently, our 
results. For instance, the disorder has been previously described as neuropsychologically 
heterogeneous (Sonuga-Barke, 2005; Sonuga-Barke, Sergeant, Nigg, & Willcutt, 2008) 
such that it cannot be easily diagnosed by means of assessing deficits in executive 
function or working memory. In addition to neuropsychological heterogeneity, there may 
be physiological heterogeneity to consider. Multiple neurological pathways—particularly 
compensatory pathways—might lead to similar cognitive outcomes. Thus, individuals 
may differ in the physiological underpinnings of the disorder, yet still exhibit the same 
degree of cognitive ability or disability, consequently making it difficult to identify a 
specific dysfunctional network that applies to all affected individuals.   
4.3 Future Research 
Aforementioned explanations for a lack of group and medication effects in the 
present study, coupled with similar problems noted in previous work, highlights the 
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difficulties inherent in conducting imaging research with the adult ADHD population. As 
a result, further research is required to better elucidate which specific components and/or 
processes of working memory are impaired in ADHD and which factors contribute to and 
modulate working memory function the most (ADHD subtype, cortical region, 
medication, age, gender). Having a clearer grasp of these factors could produce a more 
targeted approach to measuring specified areas of deficit, rather than continuing to take 
the more global approach to understanding PFC functioning in ADHD.  
To this end, future controlled studies should aim to parse out the above factors as 
best as possible. For example, studies involving a larger cohort, and comparing 
participants with ADHD only (if possible) to participants with ADHD and comorbid 
disorders (e.g. depression, anxiety) is warranted. Additionally, despite the fact that the 
literature to this point indicates no major functional differences in working memory 
between ADHD subtypes, including an analysis of differences between ADHD 
subgroups may also be informative with much larger samples. 
Another direction for future research would be to include a control task that 
targets an area of functioning known not to be negatively impacted in ADHD (e.g., 
language). This would be useful in comparing imaging data (i.e., how brain activity looks 
during a task participants are able to successfully complete compared to a task they 
struggle with) and ultimately strengthen future analyses and help identify how brain 
physiology is altered in ADHD. Additionally, outside of examining pharmacological 
interventions, investigating the effect of a neuropsychological treatment (e.g., a cognitive 
training program) on cognitive functioning in ADHD could be informative in 
determining if other treatments similarly affect (or lack an effect on) cognitive 
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functioning in this population. 
Lastly, this study is only one of a handful that have begun to explore the potential 
application of fNIRS to clinical populations. Relative to other neuroimaging 
technologies, fNIRS is still a new and developing technology. In order to better validate 
the utility of fNIRS and its output, future studies comparing measurements of fNIRS with 
a presently accepted approach (such as fMRI) on the same individuals completing the 
same task should be conducted. fNIRS measurement has the potential to be a powerful 
and useful tool for evaluation of neuropsychological disorders including ADHD; however 
there are still gaps in the technology that need to be filled before moving to the clinic.  
 
60 





American Psychiatric Association Diagnostic and Statistical Manual of Mental 
Disorders. Washington, DC: American Psychiatric Association, 2000. 
 
Agay, N., Yechiam, E., Carmel, Z., & Levkovitz, Y. (2010). Non-specific effects of 
methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and 
healthy adults. Psychopharmacology (Berl), 210(4), 511-519.  
 
Alexander, G.E, Furey, M.L., Grady, C.L., Pietrini, P., Brady, D.R., Mentis, M.J., & 
Schapiro, M.B. (1997). Association of premorbid intellectual function with 
cerebral metabolism in Alzheimer’s disease: implications for the cognitive reserve 
hypothesis. Am J Psychiat, 154(2), 165-172. 
 
Arenth, P.M., Ricker, J.H., & Schultheis, M.T. (2007). Applications of functional near-
infrared spectroscopy (fNIRS) to Neurorehabilitation of cognitive disabilities. 
Clin Neuropsychol, 21(1), 38-57. 
 
Aron, A.R., & Poldrack, R.A. (2005). The cognitive neuroscience of response inhibition: 
Relevance for genetic research in attention-deficit/hyperactivity disorder. 
Biological Psychiatry, 57(11), 1285-1292.  
 
Ayaz, H. (2010). Functional Near Infrared Spectroscopy Based Brain Computer 
Interface. School of Biomedical Engineering, Science & Health Systems. PhD 
Thesis Drexel University, Philadelphia, PA, p. 214.  
 
Ayaz, H., Izzetoglu, M., Platek, S. M., Bunce, S., Izzetoglu, K., Pourrezaei, K., & Onaral, 
B. (2006). Registering fNIR data to brain surface image using MRI templates. 
Conf Proc IEEE Eng Med Biol Soc, 2671-2674.  
 
Ayaz, H., Izzetoglu, M., Shewokis, P.A., & Onaral, B. (2010). Sliding-window motion 
artifact rejection for functional near-infrared spectroscopy. Conf Proc IEEE Eng 
Med Biol Soc, 6567-6570.  
 
Ayaz, H., Shewokis, P., Bunce, S., Schultheis, M., & Onaral, B. (2009). Assessment of 
Cognitive Neural Correlates for a Functional Near Infrared-Based Brain 
Computer Interface System. In D. Schmorrow (Ed.), Foundations of Augmented 
Cognition. Neuroergonomics and Operational Neuroscience (pp. 699-708). 
 
Ayaz, H., Shewokis, P.A., Bunce, S., Izzetoglu, K., Willems, B., & Onaral, B. (2012). 
Optical brain monitoring for operator training and mental workload assessment. 
NeuroImage, 59(1), 36-47. 
 
61 
Ayaz, H., Shewokis, P.A., Curtin, A., Izzetoglu, M., Izzetoglu, K., & Onaral, B. (2011). 
Using MazeSuite and Functional Near Infrared Spectroscopy to study learning in 
spatial navigation. J Vis Exp, 56, e3443. 
 
Ayaz, H., Willems, B., Bunce, B., Shewokis, P. A., Izzetoglu, K., Hah, S., . . . Onaral, B. 
(2010). Cognitive Workload Assessment of Air Traffic Controllers Using Optical 
Brain Imaging Sensors. In T. Marek, W. Karwowski & V. Rice (Eds.), Advances 
in Understanding Human Performance: Neuroergonomics, Human Factors 
Design, and Special Populations (pp. 21-31): CRC Press Taylor & Francis Group. 
 
Baddeley, A. (1986). Working memory. Oxford, England: Clarendon Press. 
 
Barkley, R.A., DuPaul G.J., & McMurraym M.B. (1991). Attention deficit disorder with 
and without hyperactivity: clinical response to three dose levels of 
methylphenidate. Pediatrics, 87(4), 519-31. 
 
Barkley, R.A., Fischer, M., Smallish, L., & Fletcher, K. (2002). The persistence of 
attention-deficit/hyperactivity disorder into young adulthood as a function of 
reporting source and definition of disorder. Journal of Abnormal Psychology, 
111(2), 279-289. 
 
Barkley, R.A. (2011). Barkley Adult ADHD Rating Scale-IV (BAARS-IV). New York, 
NY:  Guilford Press. 
 
Barnett, J.H., Salmond, C.H., Jones, P.B., & Sahakian, B.J. (2006). Cognitive reserve in 
neuropsychiatry. Psychol Med, 36(8), 1053-1064. 
 
Bennett, D.A., Wilson, R.S., Schneider, J.A., Evans, D.A., Mendes de Leon, C.F., 
Arnold, S.E., … Bienias, J.L. (2003). Education modifies the relation of AD 
pathology to level of cognitive function in older persons. Neurology, 60(12), 
1909-1915. 
 
Biederman, J., Mick, E., & Faraone, S.V. (2000). Age-dependent decline of ADHD 
symptoms revisited: impact of remission, definition, and symptom subtype. Am J 
Psychiatry, 157(5), 816-818.  
 
Biederman. J., Monuteaux, M.C., Mick, E., Spencer, T., Wilens, T.E., Silva, J.M., . . . 
Faraone, S.V. (2006). Young adult outcome of attention deficit hyperactivity 
disorder: A controlled 10-year follow-up study. Psychological Medicine, 36(2), 
167-179.  
 
Biederman, J., Seidman, L.J., Petty, C.R., Fried, R., Doyle, A.E., Cohen, D.R., . . . 
Faraone, S.V. (2008). Effects of stimulant medication on neuropsychological 
functioning in young adults with attention-deficit/hyperactivity disorder. J Clin 
Psychiatry, 69(7), 1150-1156.  
 
62 
Boonstra, A.M., Oosterlaan, J., Sergeat, J.A., & Buitelaar, J.K. (2005). Executive 
functioning in adult ADHD: a meta-analytic review. Psychological Medicine, 
35(8), 1097-1108. 
 
Braver, T.S., Cohen, J.D., Nystrom, L.E., Jonides, J., Smith, E.E., & Noll, D.C. (1997). A 
parametric study of prefrontal cortex involvement in human working memory. 
NeuroImage, 5(1), 49-62. 
 
Brinckman, D., Schultheis, M.T., Ehrhart, L. Weisser, V., Medaglia, J., & Merzagora, A. 
(2012, November). Demonstration of Diurnal Patterns of Brain Activity Using 
fNIRS. Poster presented at the Conference of the National Academy of 
Neuropsychology, Nashville, TN. 
 
Bush, G., Spencer, T.J., Holmes, J., Shin, L.M., Valera, E.M., Seidman, L.J., . . . 
Biederman, J. (2008). Functional magnetic resonance imaging of methylphenidate 
and placebo in attention-deficit/hyperactivity disorder during the multi-source 
interference task. Arch Gen Psychiatry, 65(1), 102-114.  
 
Bush, G., Valera, E.M., & Seidman, L.J. (2005). Functional Neuroimaging of Attention-
Deficit/Hyperactivity Disorder: A Review and Suggested Future Directions. Biol 
Psychiatry, 57(11), 1273-1284. 
 
Cairo, T.A., Liddle, P.F., Woodward, T.S., & Ngan, E.T. (2004). The influence of 
working memory load on phase specific patterns of cortical activity. Brain Res 
Cogn Brain Res, 21(3), 377-387. 
 
Cameron, M.I., & Robinson, V.M. (1980). Effects of cognitive training on academic and 
on-task behavior of hyperactive children. J Abnorm Child Psychol, 8(3), 405-419. 
 
Centers for Disease Control and Prevention (CDC). (2010, November 12). Increasing 
Prevalence of Parent-Reported Attention-Deficit/Hyperactivity Disorder Among 
Children - United States, 2003 and 2007. Morbidity and Mortality Weekly Report 
(MMWR), 59(44), 1439-1443. Retrieved from 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5944a3.htm 
 
Chance, B., Anday, E., Nioka, S., Zhou, S., Hong, L., Worden, K., . . . Thomas, R. 
(1998). A novel method for fast imaging of brain function, non-invasively, with 
light. Optics Express, 2(10), 411-423.  
 
Chance, B., Zhuang, Z, UnAh, C., Alter, C., & Lipton, L. (1993). Cognition-activated 
low-frequency modulation of light absorption in human brain. Proc Natl Acad Sci 
USA, 90(8), 3770–3774. 
 
Cherkasova, M.V., & Hechtman, L. (2009). Neuroimaging in attention-deficit 




Cubillo, A., Halari, R., Smith, A., Taylor, E., & Rubia, K. (2012). A review of fronto-
striatal and fronto-cortical brain abnormalities in children and adults with 
Attention-Deficit/Hyperactivity Disorder (ADHD) and new evidence for 
dysfunction in adults with ADHD during motivation and attention. Cortex, 48(2), 
194-215. 
 
Cubillo, A., & Rubia, K. (2010). Structural and functional brain imaging in adult 
Attention deficit hyperactivity disorder (ADHD): A review. Expert Reviews of 
Neurotherapeutics, 10(4), 603-620. 
 
Davidson, M.A. (2008). Literature Review: ADHD in Adults : A Review of the 
Literature. Journal of Attention Disorders, 11(6), 628-641. 
 
Dickstein, S.G., Bannon, K., Castellanos, F.X., & Milham, M.P. (2006). The neural 
correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J 
Child Psychol Psychiatry, 47(10), 1051-1062. 
 
Duncan, J., & Owen, A.M. (2000). Common regions of the human frontal lobe recruited 
by diverse cognitive demands. Trends Neurosci, 23(10), 475-483. 
 
Durston, S., Hilleke, E., Hulshoff, P., Casey, B.J., Giedd, J.N., Buttlelaar, J.K., & 
VanEngeland, H. (2001). Anatomical MRI of the developing human brain: What 
have we learned? Journal of the American Academy of Child and Adolescent 
Psychiatry, 40(9), 1012-1020. 
 
Ehlis, A.,C., Bahne, C.G., Jacob, C.P., Herrmann, M.J., & Fallgatter, A.J. (2008). 
Reduced lateral prefrontal activation in adult patients with attention-
deficit/hyperactivity disorder (ADHD) during a working memory task: A 
functional near-infrared spectroscopy (fNIRS) study. Journal of pediatric 
research, 42(13), 1060-1067.  
 
Elkins, J.S., Longstreth, W.T., Monolio, T.A., Newman, A.B., Bhadelia, R.A., & 
Johnson, S.C. (2006). Education and the cognitive decline associated with MRI-
defined brain infarct. Neurology, 67(3), 435-440. 
 
Epstein, J.N., Casey, B.J., Tonev, S.T., Davidson, M.C., Reiss, A.L., Garrett, A., . . . 
Spicer, J. (2007). ADHD and medication-related brain activation effects in 
concordantly affected parent-child dyads with ADHD. J Child Psychol 
Psychiatry, 48(9), 899-913.  
 
Fallgatter, A.J., Ehlis, A., Wagener, A., Michel, T., & Herrmann, M.J. (2004). Nah-
Infrarot-Spektroskopie in der Psychiatrie [Near-infrared spectroscopy in 
psychiatry]. Nervenarzt, 75(9), 911-916.  
 
64 
Faraone, S.V., & Biederman, J. (2005) What is the prevalence of adult ADHD? Results 
of a population screen of 966 adults. Journal of Attention Disorders, 9(2), 384-
391. 
 
Faraone, S.V., Biederman, J., Spencer, T., Wilens, T., Seidman, L.J., Mick, E., & Doyle, 
A.E. (2000). Attention-deficit/hyperactivity disorder in adults: an overview. Biol 
Psychiatry, 48(1), 9-20. 
 
Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, & Kahn RS. (2007). 
Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder 
in a national sample of US children. Archives of pediatrics and adolescent 
medicine, 161(9), 857-864. 
 
Gervain, J., Mehler, J., Werker, J.F., Nelson, C.A., Csibra, C., Lloyd-Fox, S., . . . Aslin, 
R.N. (2011). Near-Infrared Spectroscopy: A Report from the McDonnell Infant 
Methodology Consortium. Developmental Cognitive Neuroscience, 1(1), 22-46. 
 
Grattan, L.M., & Eslinger, P. J. (1991). Frontal lobe damage in children and adults: A 
comparative review. Developmental Neuropsychology, 7(3), 283-326. 
 
Greenhill, L., Beyer, D., Finkleson, J., Shaffer, D., Biederman, J., Conners, C., . . .  
Volkow, N. (2002). Guidelines and algorithms for the use of methylphenidate in 
children with Attention-Deficit/ Hyperactivity Disorder. Journal of Attention 
Disorders, 6(Supp1), s89-s100.  
 
Hale, T.S., Bookheimer, S., McGough, J.J., Phillips, J.M., & McCracken, J.T. (2007). 
Atypical brain activation during simple and complex levels of processing in adult 
ADHD: an fMRI study. Journal of Attention Disorders, 11(2), 125-140. 
 
Halperin, J.M., & Healey, D.M. (2011). The influences of environmental enrichment, 
cognitive enhancement, and physical exercise on brain development: can we alter 
the developmental trajectory of ADHD? Neurosci Biobehav Rev, 35(3), 621-634. 
 
Hechtman, L. (1992). Long-term outcome in attention-deficit/hyperactivity disorder. 
Psychiatr Clin North Am, 1, 553-565.  
 
Herrmann, M.J., Ehlis, A.C., & Fallgatter, A.J. (2004). Bilaterally reduced frontal 
activation during a verbal fluency task in depressed patients as measured by near-
infrared spectroscopy. J Neuropsychiatry Clin Neurosci, 16(2), 170-175.  
 
Herrmann, M.J., Plichta, M.M., Ehlis, A.C., & Fallgatter, A.J. (2005). Optical topography 
during a Go- NoGo task assessed with multi-channel near-infrared spectroscopy. 
Behav Brain Res, 160(1), 135-140.  
 
65 
Hervey, A., Epstein, J.N., & Curry, J.F. (2004). Neuropsychology of Adults With 
Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. 
Neuropsychology, 18(3), 485-503. 
 
Hock, C., Villringer, K., Muller-Spahn, F., Wenzel, R., Heekeren, H., Schuh-Hofer S., . . 
. Villringer, A. (1997). Decrease in parietal cerebral hemoglobin oxygenation 
during performance of a verbal fluency task in patients with Alzheimer’s disease 
monitored by means of near-infrared spectroscopy (NIRS) - correlation with 
simultaneous rCBF-PET measurements. Brain Res, 755(2), 293-303.  
 
Huppert, T.J., Hoge, R.D., Diamond, S.G., Franceschini, M.A., & Boas, D.A. (2006). A 
temporal comparison of BOLD, ASL, and NIRS hemodynamic responses to 
motor stimuli in adult humans. Neuroimage, 29(2), 368-382. 
 
Inoue, Y., Sakihara, K., Gunji, A., Ozawa, H., Kimiya, S., Shinoda, H., . . . Inagaki, M. 
(2012). Reduced prefrontal hemodynamic response in children with ADHD 
during the Go/NoGo task: a NIRS study. Neuroreport, 23(2), 55-60. 
 
Irani, F., Platek, S.M., Bunce, S., Ruocco, A.C., & Chute, D. (2007). Functional near 
infrared spectroscopy (fNIRS): an emerging neuroimaging technology with 
important applications for the study of brain disorders. Clin Neuropsychol, 21(1), 
9-37. 
 
Izzetoglu, K., Ayaz, H., Merzagora, A., Izzetoglu, M., Shewokis, P. A., Bunce, S. C., . . . 
Onaral, B. (2011). The evolution of field deployable fNIR spectroscopy from 
bench to clinical settings. Journal of Innovative Optical Health Sciences, 4(3), 1-
12.  
 
Izzetoglu, K., Bunce, S., Onaral, B., Pourrezaei, K., & Chance, B. (2004). Functional 
optical brain imaging using near-infrared during cognitive tasks. International 
Journal of Human Computer Interaction 17(2), 211-227. 
 
Izzetoglu, M., Izzetoglu, K., Bunce, S., Ayaz, H., Devaraj, A., Onaral, B., & Pourrezaei, 
K. (2005). Functional near-infrared neuroimaging. IEEE Trans Neural Syst 
Rehabil Eng, 13(2), 153-159. 
 
Jensen, P.S., Martin, D., & Cantwell, D.P. (1997). Comorbidity in ADHD: implications 
for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry, 36(8), 
1065-1079.  
 
Jobsis, F.F. (1997). Noninvasive, infrared monitoring of cerebral and myocardial oxygen 
sufficiency and circulatory parameters. Science 198(4323), 1264-1267. 
 
Kessler, R.C., Adler, L., Barkley, R., Biederman, J., Conners, C.K., Demler, O., . . . 
Zaslavsky, A.M. (2006). The prevalence and correlates of adult ADHD in the 
66 
United States: Results from the National Comorbidity Survey Replication. 
American Journal of Psychiatry, 163(4), 716-723. 
 
Kim, B.N., Lee, J.S., Cho, S.C., & Lee, D.S. (2001). Methylphenidate increased regional 
cerebral blood flow in subjects with attention deficit/hyperactivity disorder. 
Yonsei Med J, 42(1), 19-29.  
 
Kobel, M., Bechtel, N., Weber, P., Specht, K., Klarhofer, M., Scheffler, K., . . . Penner, 
I.K. (2009). Effects of methylphenidate on working memory functioning in 
children with attention deficit/hyperactivity disorder. Eur J Paediatr Neurol, 
13(6), 516-523. 
 
Laurienti, P.J., Field, A.S., Burdette, J.H., Maldjian, J.A., Yen, Y.F., & Moody, D.M. 
(2002). Dietary caffeine consumption modulates fMRI measures. Neuroimage 
17(2), 751-757. 
 
Luce, R.D. (1986). Response Times. New York: Oxford University Press.  
 
Manoach, D.S., Schlaug, G., Siewert, B., Darby, D.G., Bly, B.M., Benfield, A., . . . 
Warach, S. (1997). Prefrontal cortex fMRI signal changes are correlated with 
working memory load. Neuroreport, 8(2), 545-549. 
 
Levin, J.M., Ross, M.H., Mendelson, J.H., Kaufman, M.J., Lange, N., Maas, . . . 
Renshaw, P.F. (1998). Reduction in BOLD fMRI response to primary visual 
stimulation following alcohol ingestion. Psychiatry Res. 82(3), 135-146. 
 
Mannuzza, S., Klein, R.G., Bessler, A., Malloy, P., & LaPadula, M. (1993). Adult 
outcome of hyperactive boys: educational achievement, occupational rank, and 
psychiatric status. Arch Gen Psychiatry, 50(7), 565–76.  
 
Matsuo, K., Kato, T., Fukuda, M., & Kato, N. (2000). Alteration of hemoglobin 
oxygenation in the frontal region in elderly depressed patients as measured by 
near-infrared spectroscopy. J Neuropsychiatry Clin Neurosci, 12(4), 465-471.  
 
Matsuo, K., Taneichi, K., Matsumoto, A., Ohtani, T., Yamasue, H., Sakano, Y., . . . Kato, 
T. (2003). Hypoactivation of the prefrontal cortex during verbal fluency test in 
PTSD: a near-infrared spectroscopy study. Psychiatry Res, 124(1), 1-10.  
 
Mehta, M.A., Owen, A.M., Sahakian, B.J., Mavaddat, N., Pickard, J.D., & Robbins, T.W. 
(2000). Methylphenidate enhances working memory by modulating discrete 
frontal and parietal lobe regions in the human brain. J Neurosci, 20(6), RC65.  
 
Merzagora, A.C., Schultheis, M.T., Onaral, B., & Izzetoglu, M. (2011). fNIR-based 
assessment of attention impairments after traumatic brain injury. Journal of 
Innovative Optical Health Sciences, 4(3), 251-260. 
 
67 
Merzagora, A.C. (2010). Functional near infrared spectroscopy in the multimodal 
assessment of working memory impairments following traumatic brain injury. 
(Doctoral dissertation). Retrieved from iDEA: Drexel E-repository and Archives. 
(http://hdl.handle.net/1860/3318) 
 
Miller, K.M., Price, C.C., Okun, M.S., Montijo, H., & Bowers, D. (2009). Is the n-back 
task a valid neuropsychological measure for assessing working memory? Arch 
Clin Neuropsychol, 24(7), 711-717.  
 
Molteni, E., Butti, M., Bianchi, A.M., & Reni, G. (2008). Activation of the prefrontal 
cortex during a visual n-back working memory task with varying memory load: A 
near infrared spectroscopy study. Conf Proc IEEE Eng Med Biol Soc. 4024-7. 
 
Monden, Y., Dan, H., Nagashima, M., Dan, I., Kyutoku, Y., Okamoto, M., . . . Watanabe, 
E. (2012). Clinically-oriented monitoring of acute effects of methylphenidate on 
cerebral hemodynamics in ADHD children using fNIRS. Clinical 
Neurophysiology 123(6), 1147-1157. 
 
Narayanan, N.S., Prabhakaran, V., Bunge, S.A., Christoff, K., Fine, E.M., & Gabrieli, 
J.D.E. (2005). The Role of the Prefrontal Cortex in the Maintenance of Verbal 
Working Memory. Neuropsychology, 19(2), 223-232.  
 
Negoro, H., Sawada, M., Iida, J., Ota, T., Tanaka, S., & Kishimoto, T. (2010). Prefrontal 
dysfunction in attention-deficit/hyperactivity disorder as measured by near-
infrared spectroscopy. Child Psychiatry Hum Dev, 41(2),193-203. 
 
Obrig, H., & Villringer, A. (2003). Beyond the visible – imaging the human brain with 
light. Journal of Cerebral Blood Flow and Metabolism, 23(1), 1-18.  
 
Owen, A.M., McMillan, K.M., Laird, A.R., & Bullmore, E. (2005). N-Back Working 
Memory Paradigm: A Meta-Analysis of Normative Functional Neuroimaging 
Studies. Human Brain Mapping, 25(1), 46-59. 
 
Paloyelis, Y., Mehta, M.A., Kuntsi, J., & Asherson, P. (2007). Functional MRI in ADHD: 
a systematic literature review. Expert Rev Neurother, 7(10), 1337-1356. 
 
Pamplona, F.A., Pandolfo, P., Savoldi, R., Prediger, R.D., & Takahashi, R.N. (2009). 
Environmental enrichment improves cognitive deficits in Spontaneously 
Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder 
(ADHD). Prog Neuropsychopharmacol Biol Psychiatry, 33(7), 1153-1160. 
 
Perchet, C., Revol, O., Fourneret, P., Mauguière, F., & Garcia-Larrea, L. (2001). 
Attention shifts and anticipatory mechanisms in hyperactive children: an ERP 
study using the Posner paradigm. Biol Psychiatry, 50(1), 44-57. 
 
68 
Posner, M.I., & Petersen, S.E. (1990). The attention system of the human brain. Annu Rev 
Neurosci 13, 25-42.  
 
Riccio, C.A., Wolfe, M., Davis, B., Romine, C., George, C., & Lee, D. (2005). Attention-
Deficit/Hyperactivity Disorder: manifestation in adulthood. Arch Clin 
Neuropsychol, 20(2), 249-269. 
 
Roe, C.M., Mintun, M.A., D’Angelo, G., Xiong, C., Grant, E.A., & Morris, J.C. (2008). 
Alzheimer disease and cognitive reserve: variation of education effect with carbon 
11 labeled Pittsburgh compound B uptake. Arch Neurol, 65(11), 1467-1471. 
 
Roy, C., & Sherrington, C. (1890). On the regulation of the blood supply of the brain. 
Journal of Physiology (London), 11(1-2), 85-108. 
 
Rubia, K., Halari, R., Cubillo, A., Mohammad, A.M., Brammer, M., & Taylor, E. (2009). 
Methylphenidate normalises activation and functional connectivity deficits in 
attention and motivation networks in medication-naive children with ADHD 
during a rewarded continuous performance task. Neuropharmacology 57(7-8), 
640-652. 
 
Rubia, K., Halari, R., Christakou, A., & Taylor, E. (2009). Impulsiveness as a timing 
disturbance: Neurocognitive abnormalities in attention-deficit hyper- activity 
disorder during temporal processes and normalization with methylphenidate. 
Philos Trans R Soc Lond B Biol Sci 364(1525), 1919-1931.  
 
Safer, D.J. & Malever, M. (2000). Stimulant treatment in Maryland public schools. 
Pediatrics, 106(3), 533-539. 
 
Schecklmann, M., Ehlis, A.C., Plichta, M.M., Romanos, J., Heine, M., Boreatti-Hummer, 
A., . . . Fallgatter, A.J. (2009). Diminished prefrontal oxygenation with normal 
and above-average verbal fluency performance in adult ADHD. Journal of 
Psychiatric Research 43(2), 98-106.  
 
Schroeter, M.L., Bucheler, M.M., Muller, K., Uludag, K., Obrig, H., Lohmann, G., … 
von Cramon, D.Y. (2004). Towards a standard analysis for functional near-
infrared imaging. Neuroimage, 21(1), 283-290. 
 
Schweitzer, J.B., Faber, T.L., Grafton, S.T., Tune, L.E., Hoffman, J.M., & Kilts, C.D. 
(2000). Alterations in the functional anatomy of working memory in adult 
attention deficit hyperactivity disorder. The American Journal of Psychiatry, 
157(2), 278-280. 
 
Schweitzer, J.B., Lee, D.O., Hanford, R.B., Tagamets, M.A., Hoffman, J.M., Grafton, 
S.T., & Kilts, C.D. (2003). A positron emission tomography study of 
methylphenidate in adults with ADHD: alterations in resting blood flow and 
predicting treatment response. Neuropsychopharmacology, 28(5), 967-73. 
69 
 
Schweitzer, J.B., Lee, D.O., Hanford, R.B., Zink, C.F., Ely, T.D., Tagamets, M.A., . . . 
Kilts, C.D. (2004). Effect of methylphenidate on executive functioning in adults 
with attention-deficit/hyperactivity disorder: normalization of behavior but not 
related brain activity. Biol Psychiatry, 56(8), 597-606.  
 
Seidman, L.J., Valera, E.M., & Bush, G. (2004). Brain function and structure in adults 
with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am, 27(2), 323-
47. 
 
Shafritz, K.M., Marchione, K.E., Gore, J.C., Shaywitz, S.E., & Shaywitz, B.A. (2004). 
The effects of methylphenidate on neural systems of attention in attention deficit 
hyperactivity disorder. Am J Psychiatry 161(11), 1990-1997. 
 
Shaw, P., Eckstrand, K., Sharp. W., Blumenthal. J., Lerch, J.P., Greenstein, D., . . . 
Rapoport J.L. (2007). Attention-deficit/hyperactivity disorder is characterized by 
a delay in cortical maturation. Proc Natl Acad Sci USA, 104(49), 19649-19654.  
 
Shaw, P., Malek, M., Watson, B., Sharp, W., Evans, A., & Greenstein, D. (2012). 
Development of cortical surface area and gyrification in attention-
deficit/hyperactivity disorder. Biol Psychiatry, 72(3), 191-197. 
 
Shinba, T., Nagano, M., Kariya, N., Ogawa, K., Shinozaki, T., Shimosato, S., . . . Hoshi, 
Y. (2004). Near- infrared spectroscopy analysis of frontal lobe dysfunction in 
schizophrenia. Biol Psychiatry, 55(2), 154-164.  
 
Silk, T., Vance, A., Rinehart, N., Egan, G., O’Boyle, M., Bradshaw, J.L., & Cunnington, 
R. (2005). Fronto-parietal activation in attention-deficit hyperactivity disorder, 
combined type: functional magnetic resonance imaging study. British Journal of 
Psychiatry, 187, 282-283. 
 
Sonuga-Barke, E.J. (2005). Causal models of attention-deficit/ hyperactivity disorder: 
from common simple deficits to multiple developmental pathways. Biol 
Psychiatry, 57(11), 1231-1238. 
 
Sonuga-Barke, E.J., Sergeant, J.A., Nigg, J., & Willcutt, E. (2008). Executive 
dysfunction and delay aversion in attention deficit hyperactivity disorder: 
nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am, 17(2), 
367-384. 
 
Sowell, E.R., Thompson, P.M., Tessner, K.D., & Toga, A.W. (2001). Mapping continued 
brain growth and gray matter density reduction in dorsal frontal cortex: Inverse 




Spencer, T., Biederman, J., & Mick, E. (2007). Attention-deficit/hyperactivity disorder: 
Diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics, 
7(1), 73-81. 
 
Sternberg, S. (1966). High-speed scanning in human memory. Science, 153(3736), 652-
654. 
 
Sternberg, S. (1969). The discovery of processing stages: Extension of Donders’ method. 
In W. G. Koster (ed.), Attention and Performance II. Amsterdam: North-Holland.  
 
Strangman, G., Boas, D.A., & Sutton, J.P. (2002). Non-invasive neuroimaging using 
near-infrared light. Biological Psychiatry, 52(7), 679-693. 
 
Strangman, G., Culver, J.P., Thompson, J.H., & Boas, D.A. (2002). A quantitative 
comparison of simultaneous BOLD fMRI and NIRS recordings during functional 
brain activation. NeuroImage, 17(2), 719-731. 
 
Stern, Y. (2006). Cognitive reserve and Alzheimer disease. Alz Dis Assoc Dis, 20(3 Suppl 
2), S69-S74.  
 
Stern, Y., Alexander, G.E., Prohovnik, I., & Mayeux, R. (1992). Inverse relationship 
between education and parietotemporal perfusion deficit in Alzheimer’s disease. 
Ann Neurol, 32(3), 371-375. 
 
Sumowski, J.F., Chiaravalloti, N., & DeLuca, J. (2009). Cognitive reserve protects 
against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsyc, 31(8), 
913-926." 
 
Sumowski, J.F., Chiaravalloti, N., Wylie, G.R., & DeLuca, J. (2009). Cognitive reserve 
moderates the negative effect of brain atrophy on cognitive efficiency in multiple 
sclerosis. J Int Neuropsych Soc, 15(4), 606-612. 
 
Sumowski, J.F., Wylie, G.R., DeLuca, J., & Chiaravalloti, N. (2010). Intellectual 
enrichment is linked to cerebral efficiency in multiple sclerosis: functional 
magnetic resonance imaging evidence for cognitive reserve. Brain, 133(2), 362-
374. 
 
Suto, T., Fukuda, M., Ito, M., Uehara, T., & Mikuni, M. (2004). Multichannel near-
infrared spectroscopy in depression and schizophrenia: cognitive brain activation 
study. Biol Psychiatry 55(5), 501-511.  
 
Swanson, J., Baler, R.D., & Volkow, N.D. (2011). Understanding the effects of stimulant 
medications on cognition in individuals with attention-deficit hyperactivity 
disorder: a decade of progress. Neuropsychopharmacology, 36(1), 207-226. 
 
71 
Szobot, C.M., Ketzer, C., Cunha, R.D., Parente, M.A., Langleben, D.D., Acton, P.D., . . . 
Rohde, L.A. (2003). The acute effect of methylphenidate on cerebral blood flow 
in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol 
Imaging, 30(3), 423-426.  
 
Taylor, E., Chadwick, O., Heptinstall, E., & Danckaerts, M. (1996). Hyperactivity and 
conduct problems as risk factors for adolescent development. Journal of the 
American Academy of Child and Adolescent Psychiatry, 35(9), 1213-1226. 
 
Topaloglu, N., Kara, E., Karahan, E., Erdogan, S.B., Serap, S., Oner, O., . . . Akin, A. 
(2008). The effect of methylphenidate on brain hemodynamics of attention-deficit 
hyperactivity disorder measured by functional near infrared spectroscopy. Front. 
Hum. Neurosci. Conference Abstract: 10th International Conference on Cognitive 
Neuroscience. 
 
Townsend, J.T., & Ashby, F.G. (1983). Stochastic modeling of elementary psychological 
processes. London: Cambridge.  
 
Vaidya, C.J., Austin, G., Kirkorian, G., Ridlehuber, H.W., Desmond, J.E., Glover, G.H., 
& Gabrieli, J.D. (1998). Selective effects of methylphenidate in attention deficit 
hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad 
Sci USA, 95(24), 14494-14499.  
 
Valera, E.M., Faraone, S.V., Biederman, J., Poldrack, R.A., & Seidman, L.J. (2005). 
Functional neuroanatomy of working memory in adults with attention-deficit/ 
hyperactivity disorder. Biological Psychiatry, 57(5), 439-447. 
 
Vance, A., Silk, T.J., Casey, M., Rinehart, N.J., Bradshaw, J.L., Bellgrove, M.A., & 
Cunnington R. (2007). Right parietal dysfunction in children with attention deficit 
hyperactivity disorder, combined type: a functional MRI study. Molecular 
Psychiatry, 12(9), 826-832. 
 
Villringer, A. (1997). Functional neuroimaging. Optical approaches. Adv Exp Med Biol, 
413, 1-18. 
 
Villringer, A., & Chance, B. (1997). Non-invasive optical spectroscopy and imaging of 
human brain function. Trends Neurosci, 20(10), 435-442.  
 
Villringer, A., Plancka, J., Hock, C., Schleinkoferc, L., & Dirnagla, U. (1993). Near 
infrared spectroscopy (NIRS): A new tool to study hemodynamic changes during 
activation of brain function in human adults. Neuroscience Letters, 154(1-2), 101-
104.  
 
Volkow, N., Wang, G., Fowler, J.S., Telang, F., Maynard, L., Logan, J., . . . Swanson, 
J.M. (2004). Evidence that methylphenidate enhances the saliency of a 
72 
mathematical task by increasing dopamine in the human brain. Am J Psychiatry 
161(7), 1173-1180.  
 
Weber, P., Lutschg, J., & Fahnenstich, H. (2005). Cerebral hemodynamic changes in 
response to an executive function task in children with attention-deficit 
hyperactivity disorder measured by near-infrared spectroscopy. Journal of 
Developmental and Behavioral Pediatrics 26(2), 105-111.  
 
Weber, P., Lutschg, J., & Fahnenstich, H. (2007). Methylphenidate-induced changes in 
cerebral hemodynamics measured by functional near-infrared spectroscopy. J 
Child Neurol, 22(7), 812-817. 
 
Wechsler, D. (2011). Wechsler Abbreviated Scale of Intelligence—Second Edition 
(WAIS-IV). Bloomington, MN: Pearson. 
 
Wilens, T.E., Biederman, J., & Spencer, T.J. (2002). Attention deficit/hyperactivity 
disorder across the lifespan. Annu Rev Med, 53, 113-131. 
 
Wilens, T.E., Faraone, S.V.,  & Biederman, J. (2004). Attention-deficit/hyperactivity 
disorder in adults. JAMA, 292(5), 619-623. 
 
Wolf, R.C., Plichta, M.M., Sambataro, F., Fallgatter, A.J., Jacob, C., Lesch, K.P., . . . 
Vasic N. (2008). Regional brain activation changes and abnormal functional 
connectivity of the ventrolateral prefrontal cortex during working memory 
processing in adults with attention-deficit/hyperactivity disorder. Human Brain 
Mapping, 30(7), 2252-2266. 
 
Wong, C.G., & Stevens, M.C. (2012). The effects of stimulant medication on working 
memory functional connectivity in attention-deficit/hyperactivity disorder. Biol 
Psychiatry, 71(5), 458-466.  
 
Woods, S.P., Lovejoy, D.W., & Ball, J.D. (2002). Neuropsychological Characteristics of 
Adults with ADHD: A Comprehensive Review of Initial Studies. The Clinical 
Neuropsychologist, 16(1), 12-34. 
 
 
 
 
 
 
 
